status	generic_name	brand_name	synonym	form	class	moa	indication	description	year_launched	date_launched	country_launched	date_shortage	year_shortage	URL	year_adr_report	year_withdrawn	date_withdrawn	country_withdrawn	reason_withdrawn	year_remarketed	unii	smiles	source
Withdrawn	Acetanilide				Analgesic	Metabolised to paracetamol	Analgesia		1886						1940	1971		Japan	Aplastic anemia		SP86R356CC	CC(=O)NC1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Acetarsol				Antimicrobial	Unknown	Syphilis|Trichomoniasis		1921						1941	1982		Mauritius	Hematologic		806529YU1N	CC(=O)NC1=CC(=CC=C1O)[As](O)(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Acetylfuratrizine				Antimicrobial	Damages ribosomal proteins	Bacterial infection		1962						1977	1977		Japan|Saudi Arabia|Venezuela	Superseded by safer products: carcinogenic		C50C4V19SU	CC(=O)NC1=NN=C(\C=C\C2=CC=C(O2)[N+]([O-])=O)C=N1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Acitretin				Retinoid	Binds to the retinoic acid receptor (RAR)	Psoriasis		1989						1989	1990		Netherlands|France	Teratogenicity		LCH760E9T7	COC1=CC(C)=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)=C1C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Acridine derivatives				Antimicrobial	Unknown	Topical disinfectant		1922						1975	1979		Denmark|Venezuela	Mutagenic				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Adenosine phosphate				Antiarrhythmic	Direct nodal inhibition	Cardiac arrhythmia		1930						1957	1973		US	Cardiovascular		415SHH325A	NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Alatrofloxacin				Antimicrobial	Inhibit DNA gyrase	Bacterial infection		1997						1998	2000		Armenia|Singapore|Europe	Liver		7QVV6I50DT	C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]1[C@H]2CN(C[C@@H]12)C3=NC4=C(C=C3F)C(=O)C(=CN4C5=C(F)C=C(F)C=C5)C(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Alclofenac				Analgesic	Inhibit COX-1 & COX-2	Analgesia		1972						1974	1977		Ireland|Cyprus|Germany|UK|Italy|New Zealand|Egypt|Greece|Denmark|Indonesia|India|Jordan|Morocco	Immunologic|Liver|Skin|Urinary tract		M9CP5H21N8	OC(=O)CC1=CC=C(OCC=C)C(Cl)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Aliskiren				Antihypertensive	Direct renin inhibitor	Hypertension		2007						2011	2011		Europe	Angioedema		502FWN4Q32	COCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Alosetron				Antispasmodic	5HT3 receptor antagonist	Irritable bowel syndrome		2000						2000	2000		US	Gastrointestinal		13Z9HTH115	CN1C2=CC=CC=C2C3=C1CCN(CC4=C(C)N=CN4)C3=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Alphacetylmethadol				Analgesic	OP1 receptor agonist	Analgesia		1993						2001	2003		US	Cardiovascular		BXF83S0HEL	CC[C@@H](OC(C)=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Alpidem				Anxiolytic	GABA-A receptor antagonist	Anxiety		1991						1994	1994		France	Liver		I93SC245QZ	CCCN(CCC)C(=O)CC1=C(N=C2C=CC(Cl)=CN12)C3=CC=C(Cl)C=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Alfaxalone		alphadolone/alphaxolone		Sedative-hypnotic	Potentiation of the GABA-A chloride channel	Anesthesia		1972						1973	1984		UK|Germany|France	Immunologic		BD07M97B2A	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Amfepramone				Psychostimulant	Norepinephrine releasing agent	Obesity		1957						1974	1975		Turkey|Sweden|Oman|UAE|Norway|Venezuela|EU|France|UK	Cardiotoxicity		Q94YYU22B8	CCN(CC)C(C)C(=O)C1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Amfetamine				Psychostimulant	TAAR1 agonist	Obesity		1939						1957	1973		US|UAE|Turkey|Oman|Malaysia|Nigeria	Drug dependence		CK833KGX7E	CC(N)CC1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Amineptine				Antidepressant	Dopamine receptor antagonist	Depression		1960						1984	1999		France|Thailand|UAE|Bangladesh|Morocco|Vietnam	Drug dependence|Liver|Skin		27T1I13L6G	OC(=O)CCCCCCNC1C2=CC=CC=C2CCC3=CC=CC=C13	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Aminoglutethimide				Anxiolytic	Steroid synthesis inhibitor	Anxiety		1960						1966	1966		US|Saudi Arabia|Norway	Endocrine		0O54ZQ14I9	CCC1(CCC(=O)NC1=O)C2=CC=C(N)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Aminophenazone		aminopyrine		Analgesic	Inhibit COX-1 & COX-2	Analgesia		1887						1936	1965		10 European countries|14 Asian countries|4 African countries|Australia|US|Canada|Chile|Brazil|Venezuela	Hematologic|Carcinogenic		01704YP3MO	CN(C)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Aminophylline				Anti-asthmatic	Nonselective phosphodiesterase inhibitor	Asthma		1908						1955	1992		Netherlands	Immune-mediated reactions		27Y3KJK423	NCCN.CN1C2=C(N=CN2)C(=O)N(C)C1=O.CN3C4=C(N=CN4)C(=O)N(C)C3=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Aminorex fumarate				Psychostimulant	Catecholamine release	Obesity		1962						1967	1967		Germany|Venezuela	Respiratory		WSK05IH80K	OC(=O)\C=C\C(O)=O.NC1=NCC(O1)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Amobarbital				Sedative-hypnotic	GABA-A receptor agonist	Hypnosedation		1961						1979	1985		Sweden|New Zealand	Respiratory depression		GWH6IJ239E	CCC1(CCC(C)C)C(=O)NC(=O)NC1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Amoproxan				Antianginal	Nonselective Î²-blocker	Angina		1969						1970	1970		France	Sensory systems|Skin		27RL57FCYM	COC1=CC(=CC(OC)=C1OC)C(=O)OC(COCCC(C)C)CN2CCOCC2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Anabolic steroids				Hormones	Androgen-receptor modulation	Aplastic anemia|Breast cancer|Osteoporosis		1952						1966	1989		Thailand|India	Androgenic effects				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Anagestone acetate				Hormones	Inhibition of ovulation	Contraception		1968						1969	1969		Worldwide	Tumorigenicity		GNT396G9QT	C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]4(C)CCCC=C14	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Anti-D immunoglobulin				Immune prophylaxis	Binds to the erythrocyte D antigen	Idiopathic thrombocytopenic purpura		1968						2000	2009		Europe	Safety concerns: hemoglobinemia		48W7181FLP		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Anti-histamine			topical	Phenothiazine derivatives	H1-antagonism	Hypersensitivity		1942						1947	1986		Malaysia|Sri Lanka	Immune-mediated reactions				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Antrafenine				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1977						1979	1984		France	Urinary tract		21FS93Y6OE	FC(F)(F)C1=CC(=CC=C1)N2CCN(CCOC(=O)C3=C(NC4=CC=NC5=CC(=CC=C45)C(F)(F)F)C=CC=C3)CC2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Aprobarbital				Sedative-hypnotic	GABA-A receptor receptor modulation	Hypnosedation		1920						1966	1985		Sweden	Respiratory depression		Q0YKG9L6RF	CC(C)C1(CC=C)C(=O)NC(=O)NC1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Aprotinin				Antifibrinolytic	Pancreatic trypsin inhibitor	Bleeding		1959						1964	2007		Worldwide	Anaphylaxis		04XPW8C0FL		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Arsenate				Chemotherapeutic agent	Oncoprotein expression	Cancer		1951						1973	1988		Austria|Spain|Italy|France|Philippines	Drug abuse|Carcinogenic		G1DBI405OK	[O-][As]([O-])([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Aspirin				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1899						1970	1986		UK|US|Hong Kong|Nigeria|Spain	Liver		R16CO5Y76E	CC(=O)OC1=CC=CC=C1C(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Astemizole				Antihistamine	H1-receptor antagonist	Allergy		1977						1986	1987		Norway|New Zealand|Philippines|US|Canada|South Africa|UAE|Mauritius|Brunei|Tanzania|Armenia|Brazil|Spain|Argentina|Singapore|India|Chile	Cardiovascular|Drug interactions		7HU6337315	COC1=CC=C(CCN2CCC(CC2)NC3=NC4=C(C=CC=C4)N3CC5=CC=C(F)C=C5)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Azaribine				Antipsoriatic	Inhibition of orotidine-5'- monophosphate decarboxylase	Psoriasis		1975						1976	1976		US|Thailand|Mauritius|Saudi Arabia|Venezuela	Hematologic|Psychiatric		K1U80DO9EB	CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N2N=CC(=O)NC2=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Barbital				Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation		1903						1913	1971		Italy	Respiratory depression		5WZ53ENE2P	CCC1(CC)C(=O)NC(=O)NC1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Beclobrate				Antilipemic	Activates PPAR	Hyperlipidemia		1985						1990	1990		Switzerland	Hepatotoxicity		USZ5MY269R	CCOC(=O)C(C)(CC)OC1=CC=C(CC2=CC=C(Cl)C=C2)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bendazac				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1983						1987	1993		Spain	Liver		G4AG71204O	OC(=O)COC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Benfluorex				Psychostimulant	Fenfluramine analogue	Obesity		1976						2003	2009		Europe	Cardiotoxicity		403FO0NQG3	CC(CC1=CC=CC(=C1)C(F)(F)F)NCCOC(=O)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Benoxaprofen				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1980						1982	1982		Worldwide	Liver|Skin|Urinary tract		17SZX404IM	CC(C(O)=O)C1=CC=C2OC(=NC2=C1)C3=CC=C(Cl)C=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Benzarone				Thrombolytic	Antagonistic on mediators of muscle contraction, direct action on smooth muscle cells	Varicose veins		1964						1987	1992		Germany|Portugal|France	Liver		23ZW4BG89C	CCC1=C(C(=O)C2=CC=C(O)C=C2)C3=C(O1)C=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Benzbromarone				Uricosuric agent	Xanthine oxidase inhibitor	Gout		1976						1994	2003		Portugal|France	Liver		4POG0RL69O	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C3=C(O1)C=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Benziodarone				Uricosuric agent	Inhibits hURAT1	Gout		1962						1964	1964		UK|France|Spain	Liver		75CL65GTYR	CCC1=C(C(=O)C2=CC(I)=C(O)C(I)=C2)C3=C(O1)C=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Benzydamine		Difflam		Analgesic	COX-1 & COX-2 inhibition	Analgesia		1967						1980	1995		Germany	Skin|Psychiatric|Sensory		4O21U048EF	CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Benzyl alcohol				Antimicrobial	Alteration of bacterial membrane permeability	Decontamination of IV lines in neonates		1972						1981	1982		Israel|US|Oman|Iraq	Metabolic acidosis		LKG8494WBH	OCC1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Benzylpenicillin sodium			topical preparations	Antimicrobial	Inhibits cell wall biosynthesis	Bacterial infection		1944						1953	1972		US|Italy|Philippines|Ethiopia|Bangladesh|India|Chile|Cyprus|Spain|Thailand|Venezuela	Skin|Immune		YS5LY7JF4N	[Na+].CC1(C)S[C@@H]2[C@H](NC(=O)CC3=CC=CC=C3)C(=O)N2[C@H]1C([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bepridil				Antiarrhythmic	Calcium channel blockers	Cardiac arrhythmia		1981						1982	2004		US	Cardiovascular		755BO701MA	CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenacetin				Analgesic	Metabolized to paracetamol?	Analgesia		1886						1978	1986		Germany	Tumorigenicity|Urinary tract		ER0CTH01H9	CCOC1=CC=C(NC(C)=O)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bezitramide				Analgesic	Unknown	Analgesia		1961						1983	2004		Netherlands	Overdose		3KXW0Y310I	CCC(=O)N1C(=O)N(C2CCN(CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4)CC2)C5=C1C=CC=C5	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bicalutamide				Chemotherapeutic agent	Androgen receptor modulation	Prostate cancer		1995						2001	2003		Canada|UK	Accelerated deaths		A0Z3NAU9DP	CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bismuth salts				Antidyspepsia	Unclear. Forms insoluble complexes	Dyspepsia		1875						1930	1978		France|Egypt|Japan|Greece|Austria|Bangladesh|Turkey|Mauritius|Oman|Cuba|India	Nervous|Cardiovascular				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bithionol				Antihelminth	Exact mechanism unclear	Worm infestation		1958						1960	1967		US|Canada|Japan	Skin		AMT77LS62O	OC1=C(Cl)C=C(Cl)C=C1SC2=CC(Cl)=CC(Cl)=C2O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Boric acid				Antimicrobial	Destruction or inhibition of growth of pathogenic organisms	Skin rash		1875						1945	1990		Ireland|Malaysia|Korea|Philippines|Thailand|Germany|Japan|Costa Rica|UK|India|Peru|US	Deaths from neurotoxicity		R57ZHV85D4	OB(O)O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bovine tissue-derived medicines				Various: heparin, glucagon, insulin, blood factors	Various	Various		1982						1986	1989		Ireland|Switzerland|France	Neurotoxicity				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bromfenac				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1997						1998	1998		US|Saudi Arabia	Liver		864P0921DW	NC1=C(CC(O)=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bromisoval				Sedative-hypnotic	Similar to barbiturates	Hypnosedation		1909						1930	1987		Netherlands	Drug dependence		469GW8R486	CC(C)C(Br)C(=O)NC(N)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bromocriptine mesylate				Anti-lactation	D2 and D3 agonist	Lactation prevention		1976						1983	1989		US	Cardiovascular|Drug interactions|Nervous system|Pregnancy|Psychiatric		FFP983J3OD	CS(O)(=O)=O.CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Brotizolam				Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation		1982						1983	1989		UK	Tumorigenicity		5XZM1R3DKF	CC1=NN=C2CN=C(C3=C(SC(Br)=C3)N12)C4=CC=CC=C4Cl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Broxyquinoline				Antiprotozoal	Production of free radicals	Amoebiasis		1960						1968	1970		Japan|UAE|Saudi Arabia	Sensory		UK4C618C8T	OC1=C2N=CC=CC2=C(Br)C=C1Br	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bucetin				Analgesic	Phenacetin analogue	Analgesia		1968						1985	1986		Germany	Urinary tract: Mutagenic|Carcinogenic		6M7CVQ8PF8	CCOC1=CC=C(NC(=O)CC(C)O)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Budipine				Antiparkinsonian	Muscarinic & NMDA receptor antagonist	Parkinson's		1979						2000	2000		Germany	Cardiovascular		L9026OPI2Z	CC(C)(C)N1CCC(CC1)(C2=CC=CC=C2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bufexamac				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1973						1973	1990		France	Skin		4T3C38J78L	CCCCOC1=CC=C(CC(=O)NO)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Buflomedil				Vasodilator	Î±-adrenergic blockade	Peripheral arterial occlusive disease		1970						1981	2006		France|Europe	Neurotoxicity; cardiotoxicity		V7I71DQ432	COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Buformin				Hypoglycemic	Reduce gluconeogenesis	Diabetes		1950						1969	1978		Germany|Austria|Belgium|Ireland	Metabolism		W2115E9C7B	CCCCNC(=N)NC(N)=N	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bumadizone				Analgesic	COX-1 & COX-2 inhibition	Rheumatism		1972						1978	1986		Oman	Hematologic		ATD81G944M	CCCCC(C(O)=O)C(=O)N(NC1=CC=CC=C1)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bunamiodyl				Radiography	Selective secretion in bile	Radiography		1958						1962	1964		US|Sweden|Venezuela	Kidney		IX9VVF69JR	CCCC(=O)NC1=C(I)C(C=C(CC)C(O)=O)=C(I)C=C1I	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Buprenorphine				Analgesic	Agonistâantagonist opioid receptor modulator	Analgesia		1978						1983	1986		Egypt	Fatalities (IV use)		40D3SCR4GZ	CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4CC5=C6C(O[C@@H]2[C@@]36CCN4CC7CC7)=C(O)C=C5	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Bupropion				Antidepressant	Norepinephrine-dopamine reuptake inhibitor	Depression		1985						1985	1986		US	Nervous system		01ZG3TPX31	CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Butamben				Anesthetic	â neuronal membrane permeability to sodium ions	Local anesthesia		1923						1947	1964		UK	Allergic|Psychiatric|Skin		EFW857872Q	CCCCOC(=O)C1=CC=C(N)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cadralazine				Antihypertensive	Peripheral arteriolar vasodilator	Hypertension		1989						1991	1992		Norway	Immunologic		8T96I3U713	CCOC(=O)NNC1=NN=C(C=C1)N(CC)CC(C)O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Camazepam				Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation		1978						1984	1984		Netherlands	Immunologic		HZ3XRH03C3	CN(C)C(=O)OC1N=C(C2=CC=CC=C2)C3=CC(Cl)=CC=C3N(C)C1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Canrenone				Antihypertensive	Diuresis, aldosterone antagonist	Aldosteronism|CHF|Hypertension		1966						1976	1986		Germany	Tumorigenicity		78O20X9J0U	C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]25CCC(=O)O5	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Carbinoxamine				Antihistamine	Competes with free histamine for binding at HA-receptor sites	Allergy		1953						1987	2008		Iraq	Neurotoxicity		982A7M02H5	CN(C)CCOC(C1=CC=C(Cl)C=C1)C2=CC=CC=N2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Carisoprodol				Muscle relaxant	Unknown	Sprain|Muscle injury		1959						2002	2007		Sweden|EU|Indonesia	Abuse		21925K482H	CCCC(C)(COC(N)=O)COC(=O)NC(C)C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cartilage + bone marrow				Antiarthritic	Unknown	Degenerative joint disease		1960						1989	1992		Germany	Skin				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Catechic extract				Antiinflammatory	Unclear	Benign prostatic hyperplasia		1972						1979	1982		France	Hematologic				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cefaloridine				Antimicrobial	Disruption of cell wall synthesis	Bacterial infection		1964						1969	1989		Spain	Nephrotoxic		LVZ1VC61HB	[O-]C(=O)C1=C(C[N+]2=CC=CC=C2)CS[C@@H]3[C@H](NC(=O)CC4=CC=CS4)C(=O)N13	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Celecoxib		Onsenal		Analgesic	COX-2 inhibitor	Familial adenomatous polyposis		2003						2006	2011		Europe	Increased risk of serious cardiovascular events		JCX84Q7J1L	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cell preparations				Antiageing	Unknown	Adjuvant; antiaging		1931						1957	1987		Austria|Germany|Switzerland	Immunologic				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cerivastatin				Antilipemic	HMG CoA reductase inhibition	Hyperlipidemia		1997						1998	2001		Worldwide	Renal|Musculoskeletal		AM91H2KS67	COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Chenodeoxycholic acid				Antilipemic	â cholesterol saturation of bile	Cholelithiasis (gallstones)		1975						1976	1987		Norway	Tumorigenicity		0GEI24LG0J	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Chloral hydrate				Sedative-hypnotic	GABA receptor modulation	Hypnosedation		1869						1986	2001		US|France|India	Tumorigenicity		418M5916WG	OC(O)C(Cl)(Cl)Cl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Chloramphenicol				Antimicrobial	Disruption of cell wall synthesis	Bacterial infection		1947						1950	1978		France|Spain|Hungary|India	Hematologic		66974FR9Q1	OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Chlormadinone acetate				Hormones	Inhibition of ovulation	Contraception		1965						1970	1972		US|UK|Italy|Egypt|Venezuela	Tumorigenicity		0SY050L61N	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Chlormezanone				Muscle relaxant	GABA receptor modulation	Anxiolytic|Muscle sprain & injury		1960						1983	1996		Worldwide	Skin|Drug dependence|Liver		GP568V9G19	CN1C(C2=CC=C(Cl)C=C2)S(=O)(=O)CCC1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Chlornaphazine				Chemotherapeutic agent	Cell hydrolysis	Polycythemia & Hodgkin's disease		1964						1964	1964		Denmark|Venezuela	Tumorigenicity		U46E473275	ClCCN(CCCl)C1=CC=C2C=CC=CC2=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Chloroform		trichloromethane		Anesthetic	Depression of the respiratory centres	Anesthesia		1847						1976	1976		Greece|Turkey|Japan|US|Panama|Saudi Arabia|Brazil|Italy|Canada|Norway|Philippines|UK|Denmark|NZL|Ethiopia|Zimbabwe|Bangladesh|Dominican Republic|Belgium|Nigeria|Ireland|Oman|Cuba|India	Cardiovascular|Liver|Tumorigenicity|Urinary tract		7V31YC746X	ClC(Cl)Cl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Chloroquine				Antiprotozoal	Cell lysis	Malaria		1939						1959	1975		Japan|Guinea Bissau	Eyes		886U3H6UFF	CCN(CC)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Chlorphentermine				Psychostimulant	TAAR1 agonist	Obesity		1962						1970Â§	1969		Germany|Venezuela	Respiratory|Cardiovascular		NHW07912O7	CC(C)(N)CC1=CC=C(Cl)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Chorionic gonadotrophin				Hormones	Spermatogenesis	Hypogonadism		1934						1961	1972		US	Immunologic		20ED16GHEB		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cianidanol				Antioxidant	Free radical scavenger	Hepatitis		1976						1980	1985		Worldwide	Hematologic		8R1V1STN48	O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C3=CC=C(O)C(O)=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cinchophen				Analgesic	Adrenal stimulation	Gout		1910						1923	1991		Germany|Italy	Liver		39Y533Z02M	OC(=O)C1=CC(=NC2=C1C=CC=C2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cinepazide				Vasodilator	Phosphodiesterase inhibition	Cerebrovascular disease		1974						1985	1988		Egypt|Spain	Hematologic		67Y4P5C84X	COC1=CC(=CC(OC)=C1OC)\C=C\C(=O)N2CCN(CC(=O)N3CCCC3)CC2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cisapride monohydrate				Prokinetic agent	5-HT4 receptor agonist	Gastro-esophageal reflux		1993						1993	2000		Philippines|Oman|US|Germany|UK|Serbia|Mauritius|Canada|Brunei|Turkey|Indonesia|Singapore|Japan|Cuba|Bahrain|Australia|Armenia|India	Cardiovascular|Drug interactions		VZV0A4I38W	O.CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(Cl)=C(N)C=C3OC	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Clobutinol				Antitussive	Unclear	Cough		1961						2004	2007		Europe|Argentina	Cardiovascular		1NY2IX043A	CC(CN(C)C)C(C)(O)CC1=CC=C(Cl)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Clioquinol				Antimicrobial	Inhibition of DNA replication	Diarrhea		1934						1964	1970		Japan|Norway|Sweden|Denmark|UAE|Nigeria|Bangladesh|Philippines|Italy|Nepal|Dominican Republic|Zimbabwe|Spain|Hong Kong|Ethiopia|Honduras|Oman|Pakistan|Ghana|Libya|Bahrain|Netherlands|Saudi Arabia|Canada	Nervous system		7BHQ856EJ5	OC1=C2N=CC=CC2=C(Cl)C=C1I	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Clobenzorex				Psychostimulant	Similar to amphetamine	Obesity		1966						1986	2000		Mauritius|US	Drug abuse|Psychiatric		4A5352XI2A	C[C@@H](CC1=CC=CC=C1)NCC2=CC=CC=C2Cl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Clofenotane				Pesticide	Interfere with voltage-gated sodium channel	Pediculosis		1945						1969	1972		US	Carcinogenicity		CIW5S16655	ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)C(Cl)(Cl)Cl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Clofibrate				Antilipemic	Activates PPAR	Hyperlipidemia		1967						1973	1978		Germany|Israel|Norway|Bangladesh	Accelerated deaths		HPN91K7FU3	CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cloforex				Psychostimulant	Similar to amphetamine	Obesity		1965						1967	1967		Germany|Sweden|Venezuela	Cardiovascular|Drug abuse|Psychiatric		2QJT5ZC1L6	CCOC(=O)NC(C)(C)CC1=CC=C(Cl)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Clomacran				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1966						1970	1982		UK	Liver		5B1UZF65WW	CN(C)CCCC1C2=CC=CC=C2NC3=CC=C(Cl)C=C13	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Clometacin				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1971						1981	1990		France	Liver|Skin|Urinary tract		L9M34YK25C	COC1=CC2=C(C=C1)C(C(=O)C3=CC=C(Cl)C=C3)=C(C)N2CC(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Clozapine				Antipsychotic	Unknown	Schizophrenia		1972						1975	1975		Finland|Singapore|Norway	Cardiovascular|Hematologic		J60AR2IKIC	CN1CCN(CC1)C2=NC3=CC(Cl)=CC=C3NC4=CC=CC=C24	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cobalt				Hematinic	As cobalamin	Iron-deficiency anemia		1951						1954	1967		US|Kuwait	Cardiovascular|Liver		3G0H8C9362	[Co]	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Codeine				Analgesic	G-protein receptor modulation	Analgesia		1832						1951	1985		Bangladesh|Malaysia	Abuse		Q830PW7520	O.COC1=C2O[C@H]3[C@@H](O)C=C[C@H]4[C@H]5CC(C=C1)=C2[C@@]34CCN5C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Co-proxamol		paracetamol + dextropropoxyphene		Analgesic	?COX-3 inhibition; agonist at mu opioid receptors	Analgesia		1957						1960	2007		Europe|India|US|Zimbabwe|New Zealand|Iraq	Overdose; respiratory depression; cardio and hepatotoxicity		CB2TL9PS0T		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Coumarin			synthetic	Anticoagulant	Vitamin K reductase inhibition	Lymphedema post- radiation		1996						1996	1996		France|Australia	Liver		A4VZ22K1WT	O=C1OC2=C(C=CC=C2)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cupric bisquinoline				Antiarthritic	Antiinflammatory with penicillamine complex	Rheumatism		1958						1967	1978		France	Neuromuscular				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cyclandelate				Vasodilator	Direct effect on vascular smooth muscle	Raynaud's disease		1987						1989	1996		US	Not effective for use		4139O1OAY2	CC1CC(CC(C)(C)C1)OC(=O)C(O)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cyclobarbital				Sedative-hypnotic	GABA-A receptor receptor agonist	Hypnosedation		1962						1974	1980		Norway|France	Drug dependence|Drug overdose		0M8A98AD9H	CCC1(C(=O)NC(=O)NC1=O)C2=CCCCC2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cyclofenil				Anti-hormone	Estrogen receptor modulation	Scleroderma		1970						1980	1987		France	Liver		J468V64WZ1	CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(OC(C)=O)C=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cyclovalone + retinol + tiratricol				Choleretic	Unknown	Hyperlipidemia|Dyspepsia|Obesity		1964						1984	1988		France	Liver				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Cyproheptadine				Antihistamine	Antihistamine, anticholinergic	Allergy|Anorexia		1961						1977	1982		Bangladesh|Malaysia|UK	Drug abuse		2YHB6175DO	CN1CCC(CC1)=C2C3=CC=CC=C3C=CC4=CC=CC=C24	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dalkon shield				Hormones	Prevention of fertilization	Contraception (IUD)		1971						1974	1974		US|UK|New Zealand	Septic abortions				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Danthron		chrysazin		Laxative	Unknown	Constipation		1959						1985	1987		Norway|Germany|Japan|US|Singapore|Canada	Tumorigenicity		Z4XE6IBF3V	OC1=C2C(=O)C3=C(O)C=CC=C3C(=O)C2=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Datura				Analgesic	Muscarinic receptor antagonist (atropine)	Asthma		1920						1962	1992		France	Drug abuse		G6W4F0V8Z3		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dequalinium chloride				Lozenges	Unknown	Disinfectant		1956						1970	1984		Greece	Low efficacy|Skin reactions		XYS8INN1I6	[Cl-].[Cl-].CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Desensitizing vaccines				Vaccines	Unknown	Viral infection		1973						1985	1989		UK	Immunologic				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dexamfetamine				Psychostimulant	Adrenergic receptor agonist	Narcolepsy|ADHD		1937						1966	1973		US|Turkey|Oman|Nigeria	Drug abuse and dependence		TZ47U051FI	C[C@H](N)CC1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dexfenfluramine				Psychostimulant	Serotonin receptor agonist	Obesity		1995						1995	1997		US|Canada|Morocco|Philippines|Lithuania|India	Cardiovascular|Respiratory		E35R3G56OV	CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Oxyphenisatin acetate				Laxative	Phenacetin analogue	Diarrhea		1971						1971	1971		Australia	Liver		U0Y1YAL65X	CC(=O)OC1=CC=C(C=C1)C2(C(=O)NC3=C2C=CC=C3)C4=CC=C(OC(C)=O)C=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Diamthazole				Antimicrobial	Unknown	Fungal infection		1951						1953	1972		US|France	Nervous system|Psychiatric		2KL01R8ZV1	CCN(CC)CCOC1=CC2=C(C=C1)N=C(S2)N(C)C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dibenzepine hydrochloride				Antidepressant	Norepinephrine reuptake inhibitor	Depression		1963						1967	1983		Sweden	Suicides		JLN0273S4Z	Cl.CN(C)CCN1C2=CC=CC=C2N(C)C3=CC=CC=C3C1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dibromsalan				Antimicrobial	Unknown	Bacterial infection		1962						1966	1975		US|Japan	Skin		N9900K2RBT	OC1=CC=C(Br)C=C1C(=O)NC2=CC=C(Br)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Diclofenac sodium				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1979						1979	1983		Philippines|Norway	Hematologic|Tumorigenicity		QTG126297Q	[Na+].[O-]C(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dicycloverine				Antispasmodic	Muscarinic anticholinergic	Irritable bowel syndrome		1952						1974	1986		Bangladesh|Norway	Nervous|Psychiatric		4KV4X8IF6V	CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dienestrol				Hormones	Estrogen receptor agonist	Hormone replacement therapy		1947						1972	1977		Austria|Italy|Kuwait|Saudi Arabia	Carcinogenicity		RRW32X4U1F	C\C=C(C1=CC=C(O)C=C1)\C(=C\C)C2=CC=C(O)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Diethylaminoethoxyhexestrol				Antianginal	Unknown	Angina pectoris		1964						1970	1970		Japan	Liver		UBR09A3IFF	CCC(C(CC)C1=CC=C(OCCN(CC)CC)C=C1)C2=CC=C(OCCN(CC)CC)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Diethylstilbestrol				Hormones	Uterine desensitization, local arteriolar constriction	Threatened abortion		1938						1971	1973		Panama|Austria|Kuwait|Italy	Tumorigenicity		731DCA35BT	CC\C(C1=CC=C(O)C=C1)=C(\CC)C2=CC=C(O)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Difemerine				Antispasmodic	Muscarinic antagonist	GI spasms		1967						1980	1986		Germany|France|US	Nervous system		843C4UPZ2F	CN(C)C(C)(C)COC(=O)C(O)(C1=CC=CC=C1)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Difenoxin				Antispasmodic	Opioid receptor agonist	Diarrhea		1970						1979	1991		Pakistan|Oman|South Korea|Lebanon	Atropism		3ZZ5BJ9F2Q	OC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C4=CC=CC=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Difurazone				Antimicrobial	Unknown	Bacterial infection		1966							1977		Japan|Saudi Arabia|Venezuela	Superseded by safer products		4I203628MT	NC(=N)NN=C(C=CC1=CC=C(O1)[N+]([O-])=O)C=CC2=CC=C(O2)[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dihydrostreptomycin				Antimicrobial	Protein synthesis inhibitor	Bacterial infection		1947						1949	1970		US|Philippines|Spain|Dominican Republic|Italy|Peru	Nervous system|Psychiatric|Sensory systems		P2I6R8W6UA	CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]3NC(N)=N)O[C@@H](C)[C@]2(O)CO	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dihydroxymethylfuratrizine				Antimicrobial	Nitrofuran analogue	Bacterial infection		1975						1975	1977		Japan|Saudi Arabia|Venezuela	Tumorigenic		KZY81S445V	OCN(CO)C1=NC=C(\C=C\C2=CC=C(O2)[N+]([O-])=O)N=N1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Diiododiethyltin				Antimicrobial	Unknown	Bacterial infection		1954						1955	1957		France	Nervous system				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dilevalol				Antihypertensive	Nonselective beta blocker; beta-2 receptor agonist	Hypertension		1989						1989	1990		Worldwide	Liver		P6629XE33T	C[C@H](CCC1=CC=CC=C1)NC[C@H](O)C2=CC=C(O)C(=C2)C(N)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dinitrophenol				Organic compound	Uncoupling of oxidative phosphorylation	Obesity		1933						1933	1938â		US	Cataracts|Agranulocytosis		Q13SKS21MN	OC1=C(C=C(C=C1)[N+]([O-])=O)[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dinoprostone				Prostaglandin	Direct vasodilator	Induction of labour		1971						1987	1990		UK	Fetal distress; uterine hypertonia		K7Q1JQR04M	CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Diphenazine		quietidin		Analgesic	Unknown	Analgesia		1962						1967	1967		Hungary|Venezuela	Photosensitivity		8BEA88HVGF	CC(CC1=CC=CC=C1)N2CCN(CC2)C(C)CC3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Diphenoxylate				Antispasmodic	Opioid receptor agonist	Diarrhea		1956						1969	1990		Libya|Pakistan|Mexico|Nepal|Philippines|South Korea|Lebanon|Thailand	Nervous system		73312P173G	CCOC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C4=CC=CC=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dithiazanine iodide				Antihelminth	Interruption of glucose uptake in cells	Worm infestation		1959						1960	1964		US|France|Chad|Italy|Cuba	Cardiovascular|Metabolism		8OEC3RA07X	[I-].CCN1C(SC2=C1C=CC=C2)=CC=CC=CC3=[N+](CC)C4=C(S3)C=CC=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dofetilide				Antiarrhythmic	Potassium channel blocker	Cardiac arrhythmia		1999						1999	2004		Europe	Cardiovascular		R4Z9X1N2ND	CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC2=CC=C(NS(C)(=O)=O)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Dolasetron				Propulsive	5-HT3 receptor antagonist	Emesis		1997						2005	2011		Germany	Cardiovascular		82WI2L7Q6E	O=C(O[C@H]1C[C@@H]2C[C@@H]3C[C@@H](C1)N2CC3=O)C4=CNC5=C4C=CC=C5	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Domperidone			injectable	Propulsive	Dopamine receptor antagonist	Emesis|GERD		1979						1982	1985		Worldwide	Cardiovascular|Drug overdose|Endocrine|Nervous system		5587267Z69	ClC1=CC2=C(C=C1)N(C3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Doxycycline			IV	Antimicrobial	Protein synthesis inhibitor	Bacterial infection		1959						1984	1989		France|Morocco	Anaphylaxis		N12000U13O	O.C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C1C=CC=C4O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Drotrecogin alfa			activated	Antithrombotic	Unclear	Sepsis		2001						2001	2011		Worldwide	Insufficient evidence; bleeding risk		JGH8MYC891		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Droperidol				Antipsychotic	Dopamine 2 receptor antagonist	Psychoses		1970						1991	2001		UK|Indonesia	Cardiovascular; deaths		O9U0F09D5X	FC1=CC=C(C=C1)C(=O)CCCN2CCC(=CC2)N3C(=O)NC4=C3C=CC=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Droxicam				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1990						1992	1994		Europe	Liver		F24ADO1E2D	CN1C2=C(OC(=O)N(C2=O)C3=NC=CC=C3)C4=C(C=CC=C4)S1(=O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ebrotidine				Anti-ulcer	H2 receptor antagonist	Peptic ulcer		1997						1998	1998		Spain|Peru	Liver		TMZ3IBW2OW	NC(=N)NC1=NC(CSCCN\C=N\S(=O)(=O)C2=CC=C(Br)C=C2)=CS1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Efalizumab				Monoclonal antibody	Inhibits CD11a	Autoimmune disease		2003						2008	2009		EU|US|Canada|Mexico	Leukoencephalopathy		XX2MN88N5D		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Emetin			ipecac syrup	Emetic	Stimulation of the CTZ, local irritation	Emesis		1912						1947	1982		Mauritius	Cardiotoxicity		X8D5EPO80M	CC[C@H]1CN2CCC3=C(C=C(OC)C(OC)=C3)[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(OC)=C(OC)C=C45	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Encainide				Antiarrhythmic	Na channel blocker	Cardiac arrhythmia		1985						1989	1991		UK	Cardiovascular		SY3J0147NB	COC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2CCC3CCCCN3C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Epinephrine			topical	Anesthetic	Vasoconstriction	Local anesthesia		1899						1963	2004		Ireland|Venezuela	Cardiovascular|Nervous		YKH834O4BH	CNC[C@H](O)C1=CC(O)=C(O)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Erythrityl tetranitrate				Antihypertensive	Nitric oxide synthesis	Angina pectoris		1955						1987	1998		US	Insufficient evidence: skin		35X333P19D	[O-][N+](=O)OC[C@@H](O[N+]([O-])=O)[C@H](CO[N+]([O-])=O)O[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Erythromycin bailleul				Antimicrobial	Protein synthesis inhibitor	Bacterial infection		1955						1975	1995		France	Teratogenic				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Erythromycin estolate				Antimicrobial	Protein synthesis inhibitor	Bacterial infection		1958						1961	1976		Singapore|Greece|Sudan|Mauritius|Bangladesh|Bahrain|Denmark|Sweden	Liver		XRJ2P631HP	CCCCCCCCCCCCOS(O)(=O)=O.CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ethanol				Antimicrobial	GABA-A receptor modulation, protein coagulation	Sedation|Disinfectant		1850						1946	1985		Chile|Sri Lanka|Brazil|UAE	Neurotoxicity|Abuse		3K9958V90M	CCO	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ethchlorvynol				Sedative-hypnotic	Unknown	Hypnosedation		1955						1959	1978		US	Drug dependence|Respiratory		6EIM3851UZ	CCC(O)(\C=C\Cl)C#C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ethinyl estradiol				Hormones	?Gonadotropin suppression	Contraception		1943						1963	2004		Germany|France	Venous thrombosis		423D2T571U	C[C@]12CC[C@H]3[C@@H](CCC4=CC(O)=CC=C34)[C@@H]1CC[C@@]2(O)C#C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ethyl nitrite			spirit	Antimicrobial	Increased GFR, nitric oxide synthesis	Diaphoresis|GI spasm		1850						1977	1980		US	Methemoglobinemia		8C7CJ279RV	CCON=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ethylene dichloride			topical	Antimicrobial	Unknown	Bacterial infection		1794						1977	1978		Germany|Saudi Arabia	Carcinogenic		55163IJI47	ClCCCl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ethylestrenol				Hormones	Stimulate anabolism & inhibit catabolism	Testosterone deficiency		1964						1965	1982		Bangladesh	Inappropriate use in malnourished children		ADC79EK5Q8	CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@]12C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Etomidate				Anesthetic	GABA-A receptor modulation	Anesthesia		1972						1983	1985		UK	Endocrine		Z22628B598	CCOC(=O)C1=CN=CN1[C@H](C)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Etretinate				Retinoid	Inhibits cell differentiation & hyperkeratinization	Psoriasis		1981						1982	1992		Norway|Brazil|France|US|Canada	Teratogenicity|Tumorigenicity|Death		65M2UDR9AG	CCOC(=O)\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)C=C(OC)C(C)=C1C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Exifone				Psychostimulant	Free radical scavenger?	Memory deficits		1988						1989	1989		France	Liver		38K9TOD4EG	OC1=CC=C(C(=O)C2=CC(O)=C(O)C(O)=C2)C(O)=C1O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Factor IX				Anti-hemophilic	Hydrolysis of disulfide bonds	Hemophilia		1952						1986	1986		Sweden	HIV		382L14738L		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Factor VIII				Anti-hemophilic	Cofactor for factor IXa	Hemophilia		1965						1986	1986		UK	HIV		5T6B772R4Q		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Febarbamate				Sedative-hypnotic	GABA-A receptor receptor modulation	Hypnosedation		1967						1991	1997		France	Liver		5Z48ONN38P	CCCCOCC(CN1C(=O)NC(=O)C(CC)(C1=O)C2=CC=CC=C2)OC(N)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Felbamate				Anti-epileptic	NMDA receptor antagonist	Epilepsy		1993						1993	1994		US|European Union	Hematologic|Liver		X72RBB02N8	NC(=O)OCC(COC(N)=O)C1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Fenbutrazate				Psychostimulant	Phenmetrazine analogue	Obesity		1957						1963	1969		Europe	Drug abuse|Psychiatric		BKY8H56395	CCC(C(=O)OCCN1CCOC(C1C)C2=CC=CC=C2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Fenclofenac				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1978						1984	1984		Worldwide	Skin|Tumorigenicity|Urinary tract		Y01JW64D01	OC(=O)CC1=CC=CC=C1OC2=CC=C(Cl)C=C2Cl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Fenclozic acid				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1969						1970	1970		UK|US	Liver		58SRQ4DV53	OC(=O)CC1=CSC(=N1)C2=CC=C(Cl)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Fenetylline				Psychostimulant	Amphetamine + theophylline properties	ADHD|Narcolepsy		1961						1962	1991		Oman|Bulgaria	Abuse		YZ0N7VL5R3	CC(CC1=CC=CC=C1)NCCN2C=NC3=C2C(=O)N(C)C(=O)N3C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Fenfluramine				Psychostimulant	Serotonin receptor antagonist	Obesity		1973						1996	1997		Worldwide	Cardiovascular|Respiratory		2DS058H2CF	CCNC(C)CC1=CC(=CC=C1)C(F)(F)F	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Fenoterol				Antiasthmatic	Beta 2 adrenergic agonist	Asthma		1971						1987	1990		New Zealand|Australia	Death		22M9P70OQ9	C[C@H](CC1=CC=C(O)C=C1)NC[C@H](O)C2=CC(O)=CC(O)=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Fenproporex				Psychostimulant	Amphetamine analogue	Obesity		1966						1997	1999		Europe	Drug abuse|Psychiatric		W0194S5FOA	CC(CC1=CC=CC=C1)NCCC#N	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Fentanyl hydrochloride				Anagesic	Î¼-opioid receptor agonist	Analgesia|Anesthesia		2006						2006	2009		Europe	Risk of overdose		59H156XY46	Cl.CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Feprazone				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1978						1981	1984		UK|Germany|Greece|Egypt	Liver|Gastrointestinal|Skin|Urinary tract		7BVX6J0CGR	CC(C)=CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Fipexide				Nootropic	TAAR1 receptor modulation?	Memory deficits		1973						1990	1991		France	Hematologic|Liver		TG44VME01D	ClC1=CC=C(OCC(=O)N2CCN(CC3=CC=C4OCOC4=C3)CC2)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Floctafenine				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1976						1976	1987		Belgium	Dermatologic		O04HVX6A9Q	OCC(O)COC(=O)C1=C(NC2=CC=NC3=C(C=CC=C23)C(F)(F)F)C=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Flosequinan				Vasodilator	Direct relaxing effects	Congestive heart failure		1992						1992	1993		UK|US	Death		6NB119DLU7	CN1C=C([S+](C)[O-])C(=O)C2=C1C=C(F)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Flosulide				Analgesic	COX-2 inhibitor	Analgesia		1994						1995	1996		Germany	Kidneys		GVR41S4ZHJ	CS(=O)(=O)NC1=CC2=C(C=C1OC3=C(F)C=C(F)C=C3)C(=O)CC2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Flunitrazepam				Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation		1974						1979	1986		South Africa|Sweden	Drug abuse		620X0222FQ	CN1C2=CC=C(C=C2C(=NCC1=O)C3=CC=CC=C3F)[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Fluproquazone				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1979						1984	1989		US	Liver		U4K85O58HD	CC(C)N1C(=O)N=C(C2=CC=C(F)C=C2)C3=C1C=C(C)C=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Fluvoxamine				Antidepressant	Selective serotonin re-uptake inhibitor	Obsessive Compulsive disorder; depression		1984						1987	1987		Iceland	Teratogenicity|Renotoxicity		O4L1XPO44W	COCCCC\C(C1=CC=C(C=C1)C(F)(F)F)=N/OCCN	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Furazolidone				Antimicrobial	Disruption of bacterial DNA	Bacterial infection		1954						1965	1977		Japan|Iraq|Malaysia|South Korea|Lebanon|Yemen|India	Skin|Hematologic|Nervous|Respiratory|Sensory		5J9CPU3RE0	[O-][N+](=O)C1=CC=C(O1)C=NN2CCOC2=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Gadofosveset trisodium				Radiography	Binds to human serum albumin	Diagnostic imaging		1988						2006	2010		European Union	Kidney		XM33Q67UVH	O.[Na+].[Na+].[Na+].[Gd+3].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)C[C@H](COP([O-])(=O)OC1CCC(CC1)(C2=CC=CC=C2)C3=CC=CC=C3)N(CC([O-])=O)CC([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Gallopamil				Antiarrhythmic	Calcium channel blockers	Cardiac arrhythmia		1983						1985	2001		Turkey	Not specified: Cardiovascular		39WPC8JHR8	COC1=CC=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C(OC)=C2)C=C1OC	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ganglioside GM1			bovine	Glycolipids	Dimerization of neurotrophic factor tyrosine kinases	Peripheral neuropathies		1975						1985	1989		Germany	Nervous system		562413257Z	CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H](O[C@@]5(C[C@H](O)[C@@H](NC(C)=O)[C@@H](O5)[C@H](O)[C@H](O)CO)C(O)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)\C=C\CCCCCCCCCCCCC	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Gatifloxacin				Antimicrobial	Inhibition of DNA gyrase	Bacterial infection		1999						2002	2011		Europe|India	Dysglycemia		L4618BD7KJ	O.O.O.COC1=C(N2CCNC(C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)C4CC4.COC5=C(N6CCNC(C)C6)C(F)=CC7=C5N(C=C(C(O)=O)C7=O)C8CC8	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Gelatin				Coagulant	Unknown	Bleeding		1915						1978	1978		US	Hematologic		2G86QN327L		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Gemfibrozil				Anticholesterol	Activates peroxisome proliferator- activated receptor-alpha (PPARÎ±)	Dyslipidemia		1982						1982	1987		Norway	Negative benefit-to-harm balance		Q8X02027X3	CC1=CC=C(C)C(OCCCC(C)(C)C(O)=O)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Gemtuzumab ozogamicin				Monoclonal antibody	Binds to the CD33 antigen	Leukemia		2000						2010	2010		US	Accelerated deaths		8GZG754X6M		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Genaconazole				Antimicrobial	Interferes with the fungal synthesis of ergosterol	Fungal infection		1970						1992	1992		US	Hepatocellular cancer		1BFZ5CM687	C[C@H]([C@](O)(CN1C=NC=N1)C2=CC=C(F)C=C2F)S(C)(=O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Gentamicin			topical	Antimicrobial	Interruption of protein synthesis	Bacterial infection		1966						1976	1994		Netherlands|UAE	Resistance		T6Z9V48IKG		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Glafenine				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1965						1973	1984		Worldwide	Urinary tract		46HL4I09AH	OCC(O)COC(=O)C1=CC=CC=C1NC2=C3C=CC(Cl)=CC3=NC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Glucosamine sulphate			injection	Antiarthritic	Precursor in biochemical synthesis of glycosylated proteins and lipids	Rheumatism		1980						1981	1986		Germany|Egypt	Immune: hypersensitivity		1FW7WLR731	OS(O)(=O)=O.N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO.N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Glutethimide				Sedative-hypnotic	Similar to barbiturates	Hypnosedation		1955						1962	1980		Norway|Zimbabwe|Pakistan|France	Drug abuse|Drug dependence|Sensory systems		C8I4BVN78E	CCC1(CCC(=O)NC1=O)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Glycosaminoglycan				Antiarthritic	Unknown	Rheumatism		1975						1982	1982		Germany	Hematologic		268AW7000T		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Grepafloxacin				Antimicrobial	Inhibition of DNA gyrase	Bacterial infection		1997						1999	1999		Worldwide	Cardiovascular		L1M1U2HC31	CC1CN(CCN1)C2=CC3=C(C(=O)C(=CN3C4CC4)C(O)=O)C(C)=C2F	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Guanethidine				Antihypertensive	Sympathetic antagonist	Hypertension		1973						1978	1986		UK	Sensory systems		ZTI6C33Q2Q	NC(=N)NCCN1CCCCCCC1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Furaguanidin				Antimicrobial	Disruption of bacterial DNA	Bacterial infection		1966							1977		Japan|Venezuela	Safer alternatives		1LBX3ODF5I	NC(=N)N\N=C\C1=CC=C(O1)[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	HA-1A		Centoxin		Monoclonal antibody	Endotoxin lipopolysaccharide	Sepsis		1991						1991	1993		US	Death		908FWN27WK		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Halogenated hydroxyquinoline derivatives				Antimicrobial	Production of free radicals	Amoebic dysentery		1949						1971	1978		Denmark|Cyprus|Philippines|Bangladesh|Ghana|Turkey|Italy|Greece|Oman|UAE|India	Nervous				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Halogenated salicylanilides				Antimicrobial	Production of free radicals	Bacterial infection		1954						1964	1975		US|Japan	Skin|Eyes				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Heptabarb				Sedative-hypnotic	GABA-A receptor modulation	Convulsion		1956						1984	1984		Sweden	Drug abuse		V10R70ML23	CCC1(C(=O)NC(=O)NC1=O)C2=CCCCCC2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Herpes simplex vaccines				Vaccines	Herpes simplex antibodies	Viral infection (HSV)		1964							1984		Germany|Saudi Arabia|Venezuela	Potential hazards				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Hexachlorophene				Antimicrobial	Production of free radicals	Bacterial infection		1948						1968	1972		Germany|Japan|Turkey|Europe|USSR|Peru	Encephalopathy|Mutagenicity|Teratogenicity		IWW5FV6NK2	OC1=C(CC2=C(O)C(Cl)=CC(Cl)=C2Cl)C(Cl)=C(Cl)C=C1Cl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Hexestrol				Chemotherapeutic agent	Nonsteroidal estrogen	Prostate CA		1946						1977	1977		Austria|Italy|Kuwait|Armenia|Saudi Arabia|Venezuela	Carcinogenic		10BI795R7D	CC[C@@H]([C@@H](CC)C1=CC=C(O)C=C1)C2=CC=C(O)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Diethylaminoethoxyhexestrol		beta- diethylaminoethyl ether		Vasodilator	Coronary vasodilatation	Hypertension		1952						1963	1969		Japan	Hepatotoxicity		UBR09A3IFF	CCC(C(CC)C1=CC=C(OCCN(CC)CC)C=C1)C2=CC=C(OCCN(CC)CC)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Hexobarbital				Sedative-hypnotic	GABA-A receptor modulation	Convulsion		1945						1962	1984		Sweden	Drug abuse		AL8Z8K3P6S	CN1C(=O)NC(=O)C(C)(C1=O)C2=CCCCC2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Human placental extract				Placenta derived tissue	Unknown	Arthritis|Eczema|Acne vulgaris		1956						1988	1994		Germany|UK|India	Neurotoxicity; Immune; skin				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Hydromorphone				Analgesic	Opioid receptor agonist	Analgesia		1926						1985	2005		US|Switzerland	Overdose potential		Q812464R06	CN1CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@@H]2CCC4=O)=C35	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Hyoscine methonitrate				Antispasmodic	Muscarinic receptor antagonist	GI spasms		1947						1964	1981		Sweden	Drug abuse		K0813KQM3V	[O-][N+]([O-])=O.C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]3O[C@@H]23)OC(=O)[C@H](CO)C4=CC=CC=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ibufenac				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1961						1964	1968		UK	Liver		5V4WIX44VI	CC(C)CC1=CC=C(CC(O)=O)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Indalpine				Antidepressant	SSRI	Depression		1983						1985	1985		France	Gastrointestinal|Hematologic		V35562QSVT	C(CC1=CNC2=C1C=CC=C2)C3CCNCC3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Indometacin		Osmosin		Analgesic	COX-1 & COX-2 inhibition	Analgesia		1963						1978	1983		UK	Gastrointestinal; deaths		XXE1CET956	COC1=CC2=C(C=C1)N(C(=O)C3=CC=C(Cl)C=C3)C(C)=C2CC(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Indoprofen				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1976						1982	1983		Worldwide	Carcinogenic		CPE46ZU14N	CC(C(O)=O)C1=CC=C(C=C1)N2CC3=C(C=CC=C3)C2=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Indoramin				Vasodilator	Alpha-1 adrenoceptor antagonist	BPH|Hypertension		1981						1986	2011		UK	Cardiovascular		0Z802HMY7H	O=C(NC1CCN(CCC2=CNC3=C2C=CC=C3)CC1)C4=CC=CC=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Influenza virus, split, inactivated		pandremix		Vaccines	Antibody production	Viral infection (influenza)		2006						2010	2010		Europe	Narcolepsy				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Insulin, inhaled		Exubera		Hormones	Decreased gluconeogenesis	Diabetes		2006						2008	2008		US|Europe	Lung cancer				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Interferon-gamma-1b				Immunomodulator	Binds directly to the type II interferon gamma receptor IFNGR1	Idiopathic pulmonary fibrosis		2002						2007	2007		US	Accelerated deaths		21K6M2I7AG		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Iodinated casein				Hormones	Thyroxine analogue	Obesity		1944						1964	1964		US	Endocrine|Metabolism				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Iophendylate				Radiography	Unknown	Radiocontrast imaging		1946						1976	1987		UK	Nervous system		2990I809YH		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Iproniazid				Antidepressant	MAOI	Depression		1952						1958	1959		Italy|Canada	Immunologic|Liver		D892HFI3XA	CC(C)NNC(=O)C1=CC=NC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Isaxonine phosphate				Neurotrophic	Muscle reinnervation	Peripheral neuropathies		1981						1983	1984		France|Tunisia	Hematologic|Liver		S52Q6EHI7F	OP(O)(O)=O.CC(C)NC1=NC=CC=N1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Isocarboxazid				Antidepressant	MAOI	Depression		1959						1966	1974		Japan|Cuba|Venezuela	Metabolic		34237V843T	CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Isoprenaline				Cardiac stimulant	Non-selective beta-adrenergic agonist	Bradycardia & heart block|Asthma		1949						1968	1992		Sri Lanka|UK|Australia|New Zealand	Cardiovascular		L628TT009W	CC(C)NCC(O)C1=CC(O)=C(O)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Isotretinoin				Retinoid	Unknown; apoptosis	Cystic acne		1982						1983	1988		Denmark|Austria|Germany|Portugal|Norway	Teratogenicity		EH28UP18IF	CC(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(C)=C\C(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Isoxicam				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1983						1985	1985		Worldwide	Skin		8XU734C4NG	CN1C(C(=O)NC2=NOC(C)=C2)=C(O)C3=CC=CC=C3S1(=O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Kaolin				Antidiarrheal	Unknown	Diarrhea		1954						1968	1991		India|Sri Lanka	Metabolism		24H4NWX5CO	O.O.[Al+3].[Al+3].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-]	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ketoconazole				Antimicrobial	Inhibits the cytochrome P450 14Î±- demethylase	Fungal infection		1976						1981	2013		EU|Australia	Hepatotoxicity		R9400W927I	CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ketoprofen			gel	Analgesic	COX-1 & COX-2 inhibition	Analgesia		1980						1983	2008		Egypt|France	Immunologic		90Y4QC304K	CC(C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ketorolac			inj	Analgesic	COX-1 & COX-2 inhibition	Analgesia		1989						1992	1992		Germany|France|Jamaica	Gastrointestinal|Skin		YZI5105V0L	OC(=O)C1CCN2C1=CC=C2C(=O)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Lapdap		chlorproguanil + dapsone		Antimalarial	Inhibits dihydrofolate reductase	Malaria		2003						2008	2008		Worldwide	Hemolytic anemia		8O3249M729		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Laropiprant				Antilipemic	Prostaglandin receptor blocker	Facial flushing		2008						2008	2008		Worldwide	Higher frequency of non-fatal but serious side effects		G7N11T8O78	CS(=O)(=O)C1=CC(F)=CC2=C1N(CC3=CC=C(Cl)C=C3)C4=C2CC[C@@H]4CC(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Lead oxide and lead salts			topical	Astrigent	Unknown	Skin tightening		1892						1977	1980		France|Denmark|Saudi Arabia|Venezuela	Nervous (encephalopathy)				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Levacetylmethadol				Antidote	mu-opioid receptor agonist, nicotinic acetylcholine receptor antagonist	Opioid dependence		1995						2001	2001		Europe|US	Cardiovascular		R3B637Y991	CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Levamfetamine				Psychostimulant	Amphetamine analogue	Obesity		1944						1954	1973		US|Oman|UAE	Drug abuse and dependence		R87US8P740	C[C@@H](N)CC1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Levamisole				Antihelminth	Neuromuscular depolarizing blockade	Worm infestation		1966						1976	1999		US|Canada|Vietnam	Hematologic|Nervous system		2880D3468G	C1CN2C[C@@H](N=C2S1)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Norepinephrine				Vasopressor	L-norepinephrine analogue	Nonhemorrhagic shock		1904						1958	1973		Ireland|Venezuela	Nervous|Cardiovascular		X4W3ENH1CV	NC[C@H](O)C1=CC(O)=C(O)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Lindane				Insecticide	CNS stimulation	Head lice		1942						1972	2001		Brazil	Toxicity		59NEE7PCAB	Cl[C@H]1[C@H](Cl)[C@H](Cl)[C@@H](Cl)[C@H](Cl)[C@@H]1Cl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Letrozole				Hormone antagonist	Non-steroidal aromatase inhibitor	Hormonally-responsive breast cancer		2001						2005	2011		India	Teratogenic		7LKK855W8I	N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Loperamide			syrup & drops	Antidiarrheal	Opioid receptor agonist	Diarrhea		1975						1990	1990		Worldwide	Paralytic ileus		6X9OC3H4II	CN(C)C(=O)C(CCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Loxoprofen sodium				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1983						1993	2000		Singapore	Colonic ulceration		NDC2M7399S	[Na+].CC(C([O-])=O)C1=CC=C(CC2CCCC2=O)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	L-Tryptophan				Antidepressant	Converted into serotonin	Depression and sleep disorders		1963						1989	1989		Worldwide	Eosinophilia-myalgia syndrome (EMS)		8DUH1N11BX	N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Lumiracoxib				Analgesic	COX-2 inhibitor	Analgesia		2006						2007	2007		Australia|US|Canada|Europe|New Zealand|Brazil|Philippines|Colombia	Liver		V91T9204HU	CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(O)=O)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Lyme disease vaccine				Vaccines	Immunogenicity	Bacterial infection (Lyme disease)		1998						2001	2002		US	Musculoskeletal (arthralgia)				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Lynestrenol				Hormones	Inhibits gonadotropin, suppression of follicle maturation	Contraception		1962						1970	1980		Australia	Tumorigenicity		N2Z8ALG4U5	C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Lysine amidotriazoate				Radiography	Unknown	Vascular diagnostics		1975						1981	1995		Germany	Cardiovascular|Hematologic|Immunologic|Urinary tract (safer alternatives)				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mazindol				Psychostimulant	Norepinephrine & dopamine reuptake inhibitor	Obesity		1970						1980	1987		Oman	Drug abuse|Psychiatric (interaction with lithium)		C56709M5NH	OC1(N2CCN=C2C3=C1C=CC=C3)C4=CC=C(Cl)C=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mebanazine				Antidepressant	MAOI	Depression		1963						1964	1975		UK	Drug interactions|Liver		Z5R55CJ4CG	CC(NN)C1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Meclozine		meclizine		Antihistamine	H1 receptor antagonist	Motion sickness		1953						1963	1963		Indonesia	Teratogenic potential		3L5TQ84570	CC1=CC(CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(Cl)C=C4)=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Medifoxamine				Antidepressant	Dopamine reuptake inhibitor; 5HT- receptor agonist	Depression		1983						1991	1999		Morocco|France	Liver		KWU7C2A1NT	CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mefenorex				Psychostimulant	Amphetamine analogue	Obesity		1966						1995	1999		Europe	Drug abuse|Psychiatric		K98M4N387W	CC(CC1=CC=CC=C1)NCCCCl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Megestrol acetate				Hormones	Progesterone receptor agonist	Contraception		1963						1975	1976		Greece|Norway|Germany|New Zealand	Tumorigenicity		TJ2M0FR8ES	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mepacrine		quinacrine		Antimicrobial	Unclear	Non-surgical sterilization		1935						1953	1998		India	Carcinogenicity; ectopic pregnancy; possibly political		H0C805XYDE	CCN(CC)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC3=CC=C(OC)C=C13	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mepazine				Antiepileptic	Unclear	Epilepsy		1955						1957	1970		US	Cardiovascular|Gastrointestinal|Hematologic|Liver|Urinary tract		PH34873A38	CN1CCCC(CN2C3=CC=CC=C3SC4=CC=CC=C24)C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mephenesin				Muscle relaxant	Spinal reflex inhibition	Sedation|Muscle relaxation		1948						1955	1976		Japan|Saudi Arabia	Cardiotoxicity		7B8PIR2954	CC1=CC=CC=C1OCC(O)CO	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Meprobamate				Muscle relaxant	GABA-A receptor modulation	Anxiety		1955						1957	1981		Sweden|Europe	Drug abuse		9I7LNY769Q	CCCC(C)(COC(N)=O)COC(N)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Thimerosal		thiomersal		Antimicrobial	Organomercury analogue	Bacterial and fungal infections		1928						1996	1999		UK|Malaysia|Brazil	Nervous system|Tumorigenicity|Urinary tract		2225PI3MOV	[Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mercury amide				Antimicrobial	Organomercury analogue	Disinfectant		1956						1964	1969		Japan|Brazil|Philippines|France|Nigeria|Ghana|Italy|Canada	Nervous system				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mercurous chloride				Antimicrobial	Organomercury analogue	Teething		1796						1949	1953		Worldwide	Nervous system		J2D46N657D	[Cl-].[Cl-].[Hg+].[Hg+]	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mesna				Detoxifying agent	Antioxidation?	Antidote for chemotherapy		1984						1985	1991		Germany	Anaphylaxis		NR7O1405Q9	[Na+].[O-]S(=O)(=O)CCS	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Metamfetamine		desoxyephedrine		Psychostimulant	TAAR1 receptor agonist	ADHD|Obesity		1944						1972	1973		US|Turkey|Oman|Nigeria	Drug abuse|Drug dependence		44RAL3456C	CN[C@@H](C)CC1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Metamizole		dipyrone		Analgesic	COX-1 & COX-2 inhibition	Analgesia		1921						1952	1965		9 European countries|11 Asian countries|and 5 African countries|Australia|US|Mexico|Canada	Hematologic|Immunologic (agranulocytosis)		934T64RMNJ	CN(CS(O)(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Methapyrilene				Sedative-hypnotic	Histamine and cholinergic receptors' antagonist	Insomnia		1947						1979	1979		Germany|Dominican Republic|UK|Italy|Canada|Singapore|Hong Kong|Australia|Egypt|Panama|Brazil|Philippines|UAE|India|Oman|Chile|New Zealand|US|Venezuela	Tumorigenicity		A01LX40298	CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Methaqualone				Sedative-hypnotic	GABA receptor agonist	Hypnosedation		1965						1966	1979		Greece|Turkey|Oman|Zimbabwe|Pakistan|Ghana|UAE|India	Drug abuse		7ZKH8MQW6T	CC1=CC=CC=C1N2C(C)=NC3=C(C=CC=C3)C2=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Methiodal sodium				Radiography	Unknown	Urinary tract diagnostics		1964						1972	1975		Sweden	Muscle		3880P18UBM	[Na+].[O-]S(=O)(=O)CI	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Metandienone				Hormones	Protein synthesis	Tonic		1960						1982	1982		US|France|UK|Germany	Endocrine (masculinization)		COZ1R7EOCC	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Methylhexanamine		DMAA		Nasal decongestant	Norepinephrine & dopamine transporter blockade	Nasal decongestion		1948						1950	1983		Worldwide	Cardiovascular|Nervous		X49C572YQO	CCC(C)CC(C)N	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Methylphenidate				Psychostimulant	Dopamine-norepinephrine reuptake inhibitor	ADHD		1956						1961	1982		Turkey|Oman|Nigeria	Drug abuse		207ZZ9QZ49	COC(=O)[C@H]([C@@H]1CCCCN1)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Methylrosanilinium chloride				Antimicrobial	Unknown	Bacterial & fungal infections		1890						1970	1998		Malaysia	Immunologic		J4Z741D6O5	[Cl-].CN(C)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(C)C)=C3C=CC(C=C3)=[N+](C)C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Methyprylon				Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation		1955						1961	1984		Zimbabwe	Drug abuse		CUT48I42ON	CCC1(CC)C(=O)NCC(C)C1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Metipranolol				Antihypertensive	Non-selective beta blocker	Hypertension		1986						1991	1991		UK	Sensory systems (uveitis)		X39AL81KEB	CC(C)NCC(O)COC1=CC(C)=C(OC(C)=O)C(C)=C1C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Metofoline				Analgesic	Opioid receptor agonist	Analgesia		1962						1965	1965		US	Sensory systems		72L4ZT2W1P	COC1=C(OC)C=C2C(CCC3=CC=C(Cl)C=C3)N(C)CCC2=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Metrizamide				Radiography	Unknown	Contrast medium		1977						1980	1992		UK|Netherlands	Nervous system|Sensory systems		RHH3W8F1CO	CN(C(C)=O)C1=C(I)C(C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO)=C(I)C(NC(C)=O)=C1I	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Urofollitropin				Hormones	GnRH agonist	Invitro fertilization (IVF)		1993						2003	2003		UK	Nervous system		W9BB98U6HP		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mianserin				Antidepressant	Norepinephrine & serotonin reuptake inhibitor	Depression		1975						1979	1988		Oman	Hematologic (agranulocytosis)		250PJI13LM	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C24	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mibefradil				Antihypertensive	Calcium channel blockers	Hypertension		1997						1998	1998		US|UK|Peru|South Africa|Jamaica|Bulgaria|Armenia	Drug interactions|Musculoskeletal		27B90X776A	COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Miglustat				Enzyme inhibitor	Glucocerebrosidase	Gaucherâs disease type 1		2002						2002	2002		Israel	Unexplained cognitive dysfunction		ADN3S497AZ	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Minaprine				Antidepressant	Reversible inhibitor of MAO-A	Depression		1972						1983	1996		France|Spain|Germany	Drug abuse|Nervous system		00U7GX0NLM	CC1=C(NCCN2CCOCC2)N=NC(=C1)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Minocycline				Antimicrobial	Protein synthesis inhibitor	Bacterial infection		1967						1974	1989		Norway	Dizziness|Vertigo		FYY3R43WGO	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C(O)=CC=C4N(C)C)C(=O)C3=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Molsidomine				Antianginal	Nitric oxide synthesis	Angina pectoris		1972						1975	1985		Germany	Tumorigenicity		D46583G77X	CCOC(=O)[N-]C1=C[N+](=NO1)N2CCOCC2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Moxisylyte		thymoxamine; uroalpha		Antianginal	Alpha1-adrenergic antagonist	Benign prostatic hyperplasia		1989						1991	1993		France	Liver		PW8QYA7KI0	CC(C)C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Mucopolysaccharide polysulfuric acid ester				Antiarthritic	Endogenous hyaluronate synthesis	Rheumatism		1962						1987	1988		Switzerland|France|Portugal|Austria	Skin: histochemical study				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	MMR vaccine		Urabe		Vaccines	Antibody production	Mumps virus		1983						1987	1988		Worldwide	Nervous system|Psychiatric				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Muzolimine				Antihypertensive	Diuresis	Hypertension		1983						1987	1987		Worldwide	Nervous system		07Z36289ZX	CC(N1N=C(N)CC1=O)C2=CC=C(Cl)C(Cl)=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Naftidrofuryl oxalate			IV	Vasodilator	5HT2 receptor antagonist	Intermittent claudication		1974						1976	1992		France|Germany|Spain	Cardiovascular|Immunologic|Liver|Urinary tract		5ADB8D9388	OC(=O)C(O)=O.CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=C3C=CC=CC3=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nandrolone decanoate			injectable	Hormones	Stimulate anabolism & inhibit catabolism	Hypogonadism		1962						1989	1997		France|Bangladesh	Drug abuse		H45187T098	CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nandrolone phenylpropionate			injectable	Hormones	Stimulate anabolism & inhibit catabolism	Hypogonadism		1959						1972	1982		Bangladesh	Drug abuse		KF7Z9K2T3W	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2OC(=O)CCC5=CC=CC=C5	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Natalizumab				Monoclonal antibody	Inhibits Î±4 integrin	Multiple sclerosis & Crohn's disease		2004						2005	2005		US	Nervous (combination)		3JB47N2Q2P		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nebacumab				Monoclonal antibody	Endotoxin-specific IgM	Sepsis		1991						1993	1993		Worldwide	Infection risk; accelerated deaths		908FWN27WK		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nefazodone				Antidepressant	5HT2 receptor antagonist	Depression		1994						1999	2003		European Union|Canada|Singapore	Hepatotoxicity		59H4FCV1TF	CCC1=NN(CCCN2CCN(CC2)C3=CC=CC(Cl)=C3)C(=O)N1CCOC4=CC=CC=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Neomycin sulfate			inj	Antimicrobial	Protein synthesis inhibitor	Bacterial infection		1949						1967	1983		Bangladesh|Philippines|Nigeria|US|Canada	Drug abuse|Sensory systems|Urinary tract		057Y626693		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nevirapine				Antimicrobial	Non-nucleoside reverse transcriptase inhibitor (NNRTI)	HIV		1996						1997	2007		Brazil	Liver		99DK7FVK1H	CC1=C2NC(=O)C3=CC=CN=C3N(C4CC4)C2=NC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nialamide				Antidepressant	MAOI	Depression		1959						1969	1974		Japan|India|Cuba|Denmark|Thailand|Venezuela|Canada	Drug interactions|Liver		T2Q0RYM725	O=C(CCNNC(=O)C1=CC=NC=C1)NCC2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nifedipine			10mg	Antihypertensive	Calcium channel blockers	Hypertension		1975						1989	1996		Australia	Cardiovascular		I9ZF7L6G2L	COC(=O)C1=C(C)NC(C)=C(C1C2=CC=CC=C2[N+]([O-])=O)C(=O)OC	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nifuroxazide		nifuroxazine		Antimicrobial	Janus kinase inhibitor	Diarrhea and colitis		1966						1997	2008		Belgium	Immunologic|Hematologic		PM5LI0P38J	OC1=CC=C(C=C1)C(=O)N\N=C\C2=CC=C(O2)[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nikethamide				Respiratory stimulant	Unclear	Tranquilizer overdose		1922						1953	1988		Worldwide	Nervous system		368IVD6M32	CCN(CC)C(=O)C1=CC=CN=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nimesulide				Analgesic	COX-2 inhibitor	Analgesia		1986						1998	1999		Portugal|Israel|Spain|Bangladesh|Nigeria|India|Ireland|Ghana|Thailand|Vietnam	Liver		V4TKW1454M	CS(=O)(=O)NC1=CC=C(C=C1OC2=CC=CC=C2)[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Niperotidine				Anti-ulcer	H2 receptor antagonist	Peptic ulcer		1990						1995	1995		Italy	Hepatotoxicity		12JBD7U72K	CN(C)CC1=CC=C(CSCCNC(NCC2=CC=C3OCOC3=C2)=C[N+]([O-])=O)O1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nitrefazole				Anti-addiction	Inhibition of aldehyde dehydrogenase	Alcohol deterrent		1982						1984	1984		Germany|Austria	Liver		VFD629099M	CC1=NC(=CN1C2=CC=C(C=C2)[N+]([O-])=O)[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nitrofurazone		Nitrofural		Antimicrobial	Unclear	Bacterial infection		1946						1974	1977		Japan|US|Armenia	Mutagenicity		X8XI70B5Z6	NC(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nitroxoline				Antimicrobial	â in the biofilm density of P. aeruginosa	UTI		1965						1966	1973		Ireland|Thailand|Venezuela	Eyes		A8M33244M6	OC1=C2N=CC=CC2=C(C=C1)[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Nomifensine				Antidepressant	Norepinephrine-dopamine reuptake inhibitor	Depression		1976						1980	1986		Worldwide	Hematologic|Liver|Respiratory		1LGS5JRP31	CN1CC(C2=CC=CC=C2)C3=CC=CC(N)=C3C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Norpseudoephedrine		Phenylpropanolamine		Psychostimulant	Adrenoreceptor agonist, D1 receptor agonist	Nasal decongestion|Obesity		1947						1985	1987		Germany|Brazil|Malaysia|Singapore|US|Oman|Canada|Cuba|India|Cameroun|Nigeria|Portugal|Temor- Leste|South Korea	Hemorrhagic stroke		27A0HLC3HH	C[C@H](N)[C@@H](O)C1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Noscapine				Antitussive	Ïâreceptor agonist	Cough		1959						1984	1990		Ireland|UK|Netherlands	Genotoxicity		8V32U4AOQU	COC1=CC=C2[C@H](OC(=O)C2=C1OC)[C@@H]3N(C)CCC4=C3C(OC)=C5OCOC5=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Novobiocin		cathomycin		Antimicrobial	Inhibitors of bacterial DNA gyrase	Staphylococcal infections		1956						1957	1987		Malaysia	Hematologic		17EC19951N	CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)O3)OC1(C)C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Omeprazole			injectable	Anti-ulcer	Proton pump inhibitor	Peptic ulcer		1989						1994	1994		Germany	Endocrine|Genotoxicity|Liver|Musculoskeletal|Nervous system|Sensory systems		KG60484QX9	COC1=CC2=C(NC(=N2)[S+]([O-])CC3=NC=C(C)C(OC)=C3C)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Opium in antitussives				Antitussive	Opioid receptor agonist	Recreation		1812						1842	1982		Bangladesh|Italy	Drug dependence				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Orciprenaline		metaprotenerol		Bronchodilator	Beta2 adrenoceptor agonist	Asthma		1961						1972	2009		UK	Cardiovascular		53QOG569E0	CC(C)NCC(O)C1=CC(O)=CC(O)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Orgotein				Antiarthritic	Free radical scavenging	Osteoarthritis		1968						1987	1990		Switzerland|Germany|Portugal	Immunologic		PKE82W49V1		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Oxeladin				Antitussive	Unclear	Cough		1972						1991	1994		Germany|France|Armenia|Canada	Carcinogenic		SNC1080T5Y	CCN(CC)CCOCCOC(=O)C(CC)(CC)C1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Oxolamine				Antitussive	Unclear	Cough		1969						1972	1984		Netherlands	Nervous system: hallucination in children		90BEA145GY	CCN(CC)CCC1=NC(=NO1)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Oxomemazine				Antitussive	Histamine and cholinergic receptors' antagonist	Cough		1937						1979	1991		European Union|US	Respiratory depression in children (SIDS)		305MB38V1C	CC(CN(C)C)CN1C2=CC=CC=C2S(=O)(=O)C3=CC=CC=C13	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Oxyphenbutazone				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1955						1974	1984		Worldwide	Hematologic: Bone marrow suppression		H806S4B3NS	O.CCCCC1C(=O)N(N(C1=O)C2=CC=C(O)C=C2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Oxyphenisatin				Laxative	âd mucosal tissue permeability	Constipation		1925						1970	1972		Worldwide	Liver		3BT0VQG2GQ	OC1=CC=C(C=C1)C2(C(=O)NC3=C2C=CC=C3)C4=CC=C(O)C=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pangamic acid				âVitaminâ	Transmethylation	Detoxification		1949						1980	1984		Greece	Mutagenic		MPQ53A9F5C	CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Paromomycin				Antimicrobial	Protein synthesis inhibitor	Bacterial infection		1959						1970	1989		Spain	Renal damage|Neuromuscular blockage and ototoxicity		61JJC8N5ZK	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Parecoxib				Analgesic	COX-2 inhibitor	Analgesia		2002						2005	2005		US|European Union	Cardiovascular|Respiratory		9TUW81Y3CE	CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pargyline				Antihypertensive	Monoamine oxidase inhibitor	Hypertension		1963						1964	1979		Germany	Interaction with tyramine		9MV14S8G3E	CN(CC#C)CC1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pectin				Antidiarrheal	âd viscosity	Diarrhea		1936						1974	1991		Libya|India|Sri Lanka	Metabolic		89NA02M4RX		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pemoline				Psychostimulant	Dopamine agonist?	ADHD|Narcolepsy		1960						1973	2005		Worldwide	Liver: hepatotoxicity		7GAQ2332NK	NC1=NC(=O)C(O1)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pentobarbital				Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation		1930						1953	1985		Sweden	Drug overdose		I4744080IR	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pentosan polysulfate sodium				Anti-thrombotic	Protective coating to the damaged bladder wall?	Cystitis|Osteoarthritis		1965						1985	1994		France|US	Hematologic: thrombocytopenia		914032762Y		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pentylenetetrazol				Circulatory & respiratory stimulant	Unclear	Convulsion		1934						1954	1982		US	Convulsion		WM5Z385K7T	C1CCN2N=NN=C2CC1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pergolide Mesylate				Anti-parkinsonian	Dopamine receptor agonist	Parkinson's		2002						2002	2007		US|Canada	Cardiovascular		55B9HQY616	CS(O)(=O)=O.CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=C3C2=CC=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Perhexiline maleate				Antianginal	Inhibits mitochondrial CPT1	Angina pectoris		1974						1974	1985		UK|Spain|France	Hypoglycemia|Liver|Musculoskeletal|Nervous system		K7V8Y90G0H	OC(=O)\C=C/C(O)=O.C(C(C1CCCCC1)C2CCCCC2)C3CCCCN3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenacetin				Analgesic	Metabolized to paracetamol	Analgesia		1887						1948	1965		16 European countries|14 Asian countries|5 African countries|4 S. American countries|New Zealand|US|Canada	Hematologic|Liver|Tumorigenicity|Urinary tract		ER0CTH01H9	CCOC1=CC=C(NC(C)=O)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenazone		antipyrine		Analgesic	COX-1 & COX-2 inhibition	Analgesia		1883						1958	1981		UAE|Malaysia|Bahrain|Germany|Iraq	Hematologic		T3CHA1B51H	CN1N(C(=O)C=C1C)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenazopyridine				Analgesic	Unclear	Urinary analgesia		1927						1978	1984		Greece	Carcinogenic		K2J09EMJ52	NC1=NC(N)=C(C=C1)\N=N\C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phendimetrazine				Psychostimulant	Norepinephrine-dopamine releasing agent	Obesity		1961						1979	1982		Turkey	Drug abuse		AB2794W8KV	C[C@H]1[C@@H](OCCN1C)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenformin				Hypoglycemic	âd gluconeogenesis	Diabetes		1957						1963	1970		15 European countries|6 Asian countries|Canada|New Zealand|Brazil|US|Ethiopia	Metabolic acidosis		DD5K7529CE	NC(=N)NC(=N)NCCC1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenicarbazide		phenylsemicarbazide		Analgesic	Unclear	Analgesia		1948						1950	1979		Ireland	Serious adverse effects: hemolytic anemia		1LR2578324	NC(=O)NNC1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenmetrazine				Psychostimulant	Norepinephrine-dopamine releasing agent	Obesity		1956						1959	1982		Turkey|Oman|Nigeria	Drug abuse		XA501VL3VR	CC1NCCOC1C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenobarbital				Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation|Convulsion		1912						1929	1985		Sweden|Mauritius|France	Abuse and intoxication; skin		YQE403BP4D	CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenol			topical	Antimicrobial	Absorption by bacteria	Bacterial infection		1867						1973	1983		Dominican Republic|Lithuania	Safer alternatives		339NCG44TV	OC1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenolphthalein				Laxative	Direct action on intestinal muscles	Constipation		1902						1953	1979		Europe|Yemen|Bangladesh|Canada|France|Morocco|Oman|Japan|Saudi Arabia|Bahrain	Skin|Metabolic|Muscular		6QK969R2IF	OC1=CC=C(C=C1)C2(OC(=O)C3=CC=CC=C23)C4=CC=C(O)C=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenoxypropazine				Antidepressant	MAOI	Depression		1961						1964	1966		UK	Drug interactions|Liver		8E92V52324	CC(COC1=CC=CC=C1)NN	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phentermine				Psychostimulant	TAAR1 agonist	Obesity		1959						1964	1981		Sweden|UAE|Mauritius|Turkey|Oman|UK|Venezuela	Drug abuse		C045TQL4WP	CC(C)(N)CC1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phentolamine mesilate				Antihypertensive	Alpha-adrenergic antagonist	Erectile dysfunction		1998						1998	2000		Singapore	Carcinogenicity		Y7543E5K9T	CS(O)(=O)=O.CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC=CC(O)=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenylbutazone				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1949						1953	1985		6 European countries|6 Asian countries|3 African countries|Chile|Panama	Hematologic|Liver|Urinary tract		GN5P7K3T8S	CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phenylephrine				Decongestant	Î±1-adrenergic receptor agonist	Mydriasis		1949						1968	1987		UK	Eyes		1WS297W6MV	CNC[C@H](O)C1=CC=CC(O)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Phthalylsulfathiazole				Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1946						1950	1982		Bangladesh	Granulocytopenia		6875L5852V	OC(=O)C1=CC=CC=C1C(=O)NC2=CC=C(C=C2)S(=O)(=O)NC3=NC=CS3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pifoxime				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1975						1975	1976		France	Nervous system|Psychiatric		5947ECZ7WH	CC(=NO)C1=CC=C(OCC(=O)N2CCCCC2)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pioglitazone				Hypoglycemic	PPARs activation	Diabetes		1999						2011	2011		Europe	Risk of bladder CA		X4OV71U42S	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pipamazine				Emetic	Phenothiazine analogue	Emesis		1959						1960	1969		US	Lack of efficacy		653552FH1N	NC(=O)C1CCN(CCCN2C3=CC=CC=C3SC4=CC=C(Cl)C=C24)CC1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pipenzolate				Anti-ulcer	Muscarinic receptor antagonist	Peptic ulcer		1960						1990	1990		Pakistan	Overdose potential		RS3K5YXV34	CC[N+]1(C)CCCC(C1)OC(=O)C(O)(C2=CC=CC=C2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Piperazine				Antihelminth	GABA receptor inhibition	Worm infestation		1949						1957	1983		Malaysia|Armenia	Immunologic|Nervous system|Tumorigenicity		1RTM4PAL0V	C1CNCCN1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pipradrol				Psychostimulant	Norepinephrine-dopamine reuptake inhibitor	Obesity|Narcolepsy|ADHD		1953						1968	1982		US|Turkey|Denmark|Venezuela	Nervous|Cardiovascular		S6I030E0DA	OC(C1CCCCN1)(C2=CC=CC=C2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pirprofen				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1982						1986	1990		Worldwide	Gastrointestinal|Liver|Urinary tract		T7KN291890	CC(C(O)=O)C1=CC=C(N2CC=CC2)C(Cl)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pituitary chorionic gonadotropin			injectable	Hormones	Ovulation trigger	Infertility		1930						1958	1972		US	Immunologic				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Podophyllum resin				Laxative	Mitotic spindle poison	Constipation		1844						1962	1970		Italy|France|Egypt	Teratogenicity		16902YVY2B		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Polidexide				Antilipemic	Anion exchange	Hyperlipidemia		1974						1977	1977		UK	Oculomucocutaneous syndrome		61TTR6T3SE		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Polyoxyethylated castor oil				Adjuvant	Unknown	Emulsifier		1970						1973	1984		Worldwide	Anaphylaxis|Hyperlipidemia				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Polyvinylpyrrolidone		Polyvidone; povidone		Adjuvant	Permeability through circulatory system	Suspending and dispersing of IV drugs		1957						1967	1983		Germany|Pakistan|Egypt|US	Metabolic: granulomatous lesions		FZ989GH94E		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Potassium arsenate				Tonic	Degradation of the aberrant retinoic acid receptor Î± fusion protein	Leukemia; Psoriasis		1878						1968	1980		US	Tumorigenicity		55K74GS94Q	[K+].O[As](O)([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Potassium canrenoate				Antihypertensive	Aldosterone antagonist	Hypertension|Ascites		1968						1985	1986		Germany	Carcinogenic		M671F9NLEA	[K+].C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Potassium chloride				Electrolyte	Replenishment of potassium stores	Hypokalemia		1962						1964	1989		Belgium|France|US|Canada	Gastrointestinal perforation		660YQ98I10	[Cl-].[K+]	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Potassium nitrate				Antihypertensive	Nitric oxide synthesis	Hypertension		1901						1975	1981		France|Egypt|Venezuela	Tumorigenicity		RU45X2JN0Z	[K+].[O-][N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Practolol				Antihypertensive	Beta-blocker	Hypertension		1970						1972	1975		Greece|Turkey|New Zealand|Denmark|Thailand|Singapore|UK|Mauritius|India|Germany|Norway|Venezuela	Gastrointestinal|Sensory systems|Skin		SUG9176GRW	CC(C)NCC(O)COC1=CC=C(NC(C)=O)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pramipexole dihydrochloride monohydrate				Antiparkinsonian	Dopamine receptor agonist	Parkinson's		1997						1999	2006		Europe	Sudden onset of sleep		3D867NP06J	O.Cl.Cl.CCCN[C@H]1CCC2=C(C1)SC(N)=N2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Prenylamine				Antianginal	Calcium channel blocker	Angina pectoris		1960						1973	1989		Worldwide	Cardiovascular: multifocal ventricular tachycardia		K2OH82Z000	CC(CC1=CC=CC=C1)NCCC(C2=CC=CC=C2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Probucol				Antioxidant	Unclear	Hyperlipidemia		1980						1989	1989		Germany|France|US	Cardiovascular: Torsade de pointes		P3CTH044XJ	CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC2=CC(=C(O)C(=C2)C(C)(C)C)C(C)(C)C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Proglumide				Anti-ulcer	Cholecystokinin antagonist	Peptic ulcer		1970						1984	1989		Japan|Germany	Respiratory		EPL8W5565D	CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pronethalol				Antihypertensive	Beta-blockade	Angina pectoris		1963						1963	1965		UK	Tumorigenicity		XBP4RT1IMQ	CC(C)NCC(O)C1=CC=C2C=CC=CC2=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Propanidid				Anesthetic	Unclear	General anesthesia		1963						1965	1983		UK|Norway|France	Immunologic reactions		AO82L471NS	CCCOC(=O)CC1=CC=C(OCC(=O)N(CC)CC)C(OC)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Propofol			children	Anesthetic	GABA-A receptor agonist, sodium channel blockade	Anesthesia		1987						1992	1992		Israel|Norway|UK|Lithuania	Metabolic|Hepatic|Nervous; deaths		YI7VU623SF	CC(C)C1=CC=CC(C(C)C)=C1O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Propyphenazone				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1951						1980	1989		Turkey|UAE|Bahrain|Ireland	Hematologic|Immunologic: Lyell's syndrome		OED8FV75PY	CC(C)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Proxibarbal				Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation		1956						1990	1998		France|Italy|Spain|Portugal and Turkey	Hematologic|Immunologic		F97OMS297F	CC(O)CC1(CC=C)C(=O)NC(=O)NC1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pseudoephedrine				Sympathomimetic	Direct action on adrenergic receptors	Nasal decongestion		1959						1963	2008		Iraq|Colombia|Thailand	Nervous|GIT|Immunologic|Cardiovascular|Teratogenic		7CUC9DDI9F	CN[C@@H](C)[C@@H](O)C1=CC=CC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pumactant				Surfactant	Lowers lung surface tension	Respiratory distress		1992						2000	2000		UK	âAccelerated deathsâ				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Purified hexavalent vaccine		Hexavac		Vaccines	Immunogenicity	Bacterial and viral infections		2000						2005	2005		Europe	Decreased immunogenicity				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pyrithyldione				Sedative-hypnotic	Similar to barbiturates	Insomnia		1940						1949	1997		Spain	Hematologic: agranulocytosis		8AB20823CK	CCC1(CC)C(=O)NC=CC1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pyritinol				Nootropic	Increased cerebrovascular blood flow	Dementia syndromes		1961						1973	1982		Bangladesh	Insufficient therapeutic value and risk of misuse		AK5Q5FZH2R	CC1=NC=C(CSSCC2=C(CO)C(O)=C(C)N=C2)C(CO)=C1O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pyrovalerone				Psychostimulant	Norepinephrine-dopamine reuptake inhibitor	Obesity|Chronic fatigue syndrome		1974						1975	1979		France	Drug abuse		VOU69C02JP	CCCC(N1CCCC1)C(=O)C2=CC=C(C)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Pyrrolizidine				Antitussive	Coating effect	Cough|Sinusitis		1967						1968	1992		Germany|Belgium|UK	Liver		U81KWZ2JKN	C1CC2CCCN2C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Rapacuronium bromide				Anesthetic	Non-depolarizing neuromuscular blocker	Anesthesia		1999						1999	2001		US	Respiratory: Bronchospasm		65Q4QDG4KC	[Br-].CCC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCCCC5)[N+]6(CC=C)CCCCC6	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Remoxipride				Antipsychotic	D2 receptor antagonist	Psychoses|Schizophrenia		1991						1993	1994		Worldwide	Hematologic		0223RD59PE	CCN1CCC[C@H]1CNC(=O)C2=C(OC)C(Br)=CC=C2OC	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Rimonabant				Psychostimulant	Cannabinoid receptor agonist	Obesity		2006						2006	2007		Europe|India	Psychiatric		RML78EN3XE	CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=CC=C(Cl)C=C3Cl)C4=CC=C(Cl)C=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Rofecoxib				Analgesic	COX-2 inhibitor	Analgesia|Osteoarthritis		1999						2002	2004		Worldwide	Cardiotoxicity		0QTW8Z7MCR	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Rosiglitazone				Hypoglycemic	âd gluconeogenesis	Diabetes		1999						2007	2011		UK|New Zealand|South Africa|India	Cardiovascular		05V02F2KDG	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C3=CC=CC=N3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Rotavirus vaccine				Vaccines	Immunogenicity	Rotavirus		1998						1999	1999		US|UK	Gastrointestinal: intussusception				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Santonin				Antihelminth	Paralysis of nerve impulses	Ascariasis		1911						1933	1978		Singapore	Neurotoxicity		1VL8J38ERO	C[C@H]1[C@@H]2CC[C@@]3(C)C=CC(=O)C(C)=C3[C@H]2OC1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sargramostim				Immunostimulator	Granulocyte macrophage colony- stimulating factor (GM-CSF)	Bone marrow transplantation		1993						1999	2008		US	Immune-mediated		5TAA004E22		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Secobarbital				Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation|Convulsion		1934						1958	1990		France|Norway|Netherlands|Ghana|New Zealand|Oman	Drug abuse		1P7H87IN75	CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Selegiline				Antiparkinsonian	MAO-B inhibitor	Parkinson's|Depression|Dementia		1982						1991	1997		US	Drug interaction		2K1V7GP655	C[C@H](CC1=CC=CC=C1)N(C)CC#C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sertindole				Antipsychotic	5HT & D2 receptor antagonist	Psychoses		1996						1996	1998		UK|Bulgaria|Spain	Cardiovascular|Death		GVV4Z879SP	FC1=CC=C(C=C1)N2C=C(C3CCN(CCN4CCNC4=O)CC3)C5=C2C=CC(Cl)=C5	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sibutramine				Psychostimulant	Serotonin-norepinephrine reuptake inhibitor	Obesity		2001						2002	2002		European Union|4 Asian countries|Australia|Canada|Mexico|New Zealand|US	Cardiovascular		WV5EC51866	CC(C)CC(N(C)C)C1(CCC1)C2=CC=C(Cl)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sitaxentan sodium				Antihypertensive	Endothelin receptor antagonist	Pulmonary arterial hypertension		2006						2009	2010		Worldwide	Hepatotoxicity		6V9JH46E20	[Na+].CC1=NOC([N-]S(=O)(=O)C2=C(SC=C2)C(=O)CC3=C(C)C=C4OCOC4=C3)=C1Cl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sodium dibunate		ethyl dibunate		Antitussive	Unclear	Cough		1963						1968	1982		Philippines	Nervous		FRS4SO3K8D	[Na+].CC(C)(C)C1=CC=C2C(C=CC(=C2S([O-])(=O)=O)C(C)(C)C)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sodium bicarbonate			pediatric	Antacid	Counteracts acidity	Indigestion		1966						1983	1997		Nepal	Safety concerns: metabolic		8MDF5V39QO	[Na+].OC([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Somatropin		growth hormone		Hormones	Binds to the human growth hormone receptor	Hypopituitary dwarfism		1973						1985	1985		Europe|Egypt|New Zealand|US|Oman|Thailand	Infection risk: Creutzfeldt-Jakob disease		NQX9KB6PCL		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sorivudine				Antimicrobial	Inhibits DNA polymerase	Herpes viral infection		1993						1993	1993		Germany|Japan	Drug interactions with 5- fluorouracil		C7VOZ162LV	OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N2C=C(\C=C\Br)C(=O)NC2=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sparfloxacin				Antimicrobial	Inhibits DNA gyrase	Bacterial infection		1993						1995	1995		Europe|US	QTc prolongation|Phototoxicity		Q90AGA787L	C[C@H]1CN(C[C@@H](C)N1)C2=C(F)C3=C(C(=O)C(=CN3C4CC4)C(O)=O)C(N)=C2F	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sparteine sulphate				Hormone analogue	Prostaglandin stimulation?	Labour		1939						1963	1979		US	Uterine tetany		GQ3J2TLZ7E	O.O.O.O.O.OS(O)(=O)=O.C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Strychnine				Aphrodisiac	Acetylcholine receptor antagonist	Impotence		1753						1882	1979		Canada|Brazil|Bangladesh|Japan|Pakistan|UAE|Philippines	Nervous		H9Y79VD43J	O=C1C[C@@H]2OCC=C3CN4CC[C@@]56[C@@H]4C[C@@H]3[C@@H]2[C@@H]5N1C7=CC=CC=C67	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfacarbamide		Sulfanilylurea		Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1946						1959	1992		Germany	Hematologic|Liver|Skin|Urinary tract		W6CD25Z4QR	NC(=O)NS(=O)(=O)C1=CC=C(N)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfadicramide		sulfacetamide		Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1942						1976	1992		Germany	Negative benefit-to-harm balance: eye|Skin|Immune		7WZ5EG263C	CC(C)=CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfadimethoxine				Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1958						1961	1966		US	Skin		30CPC5LDEX	COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfadimidine				Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1942						1954	1992		US|Germany|Armenia	Hematologic: thrombocytopenia		48U51W007F	CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfaguanidine				Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1941						1969	1971		Dominican Republic|Iran|Turkey|Pakistan|Nepal|Germany|UAE|Denmark|Venezuela	Hematologic: agranulocytosis		15XQ8043FN	NC(=N)NS(=O)(=O)C1=CC=C(N)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfamerazine sodium				Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1943						1955	1992		Germany	Hematologic; skin		JOV4UJY07O	[Na+].CC1=NC([N-]S(=O)(=O)C2=CC=C(N)C=C2)=NC=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfamethizole				Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1953						1963	1984		Sweden	Immunologic		25W8454H16	CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfamethoxydiazine				Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1962						1968	1988		Germany	Skin		3L179F09D6	COC1=CN=C(NS(=O)(=O)C2=CC=C(N)C=C2)N=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfamethoxypyridazine				Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1957						1958	1984		Sweden|Pakistan|UAE|UK|Canada|Argentina|France	Hematologic|Skin		T034E4NS2Z	COC1=CC=C(NS(=O)(=O)C2=CC=C(N)C=C2)N=N1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfanilamide				Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1936						1957	1992		Germany	Sensory|Immunologic		21240MF57M	NC1=CC=C(C=C1)S(N)(=O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfathiazole				Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1941						1954	1970		US|Philippines|Dominican Republic|France|UAE|India	Hematologic|Liver|Skin|Urinary tract		Y7FKS2XWQH	NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CS2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfisomidine				Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1952						1972	1992		Germany	Negative benefit-to-harm balance		W03L3ODK6E	CC1=NC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Sulfonamides			topical	Antimicrobial	Inhibits dihydropteroate synthetase	Bacterial infection		1930						1957	1986		Chile	Immune-mediated				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Suloctidil				Vasodilator	Calcium channel blockade, inhibits thromboxane B2	Intermittent claudication		1975						1983	1985		Worldwide	Liver: hepatotoxicity		XV1N1XY17K	CCCCCCCCN[C@@H](C)[C@H](O)C1=CC=C(SC(C)C)C=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Suprifen with tussilax				Antitussive	Unknown	Cough		1971						1971	1972		France|Germany	Liver: hepatotoxicity				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Suprofen				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1983						1986	1986		Worldwide	Urinary tract		988GU2F9PE	OC[C@@H](O)[C@@H](O)CC(=O)C=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Suxibuzone				Analgesic 99m	COX-1 & COX-2 inhibition	Analgesia		1974						1982	1986		Oman|Italy	Carcinogenesis		86TDZ5WP2B	CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	technetium (99m TC) fanolesomab		Tc		Radiography	Radioisotope	Radiographic imaging		2004						2005	2005		US	Cardiovascular		AMF7KOE318		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tegaserod				Antispasmodic	5-HT4 receptor agonist	Irritable bowel syndrome|Constipation		2002						2004	2007		US|Canada|India|Jordan|Australia|Switzerland|China|Argentina	Cardiovascular		458VC51857	CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Temafloxacin				Antimicrobial	Inhibits DNA gyrase	Bacterial infection		1991						1992	1992		Worldwide	Hematologic|Immunologic|Liver|Metabolism|Urinary tract		1WZ12GTT67	CC1CN(CCN1)C2=CC3=C(C=C2F)C(=O)C(=CN3C4=CC=C(F)C=C4F)C(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Temazepam			gel capsules	Sedative-hypnotic	GABA-A receptor binding	Hypnosedation		1969						1981	1999		Australia	Drug abuse		CHB1QD2QSS	CN1C2=CC=C(Cl)C=C2C(=NC(O)C1=O)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Terconazole				Antimicrobial	Disrupts cell membrane permeability by cytochrome P450 14-alpha-demethylase	Fungal infection		1980						1988	1991		Sweden|Germany	Immunologic|Skin		0KJ2VE664U	CC(C)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=NC=N4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Terfenadine				Antihistamine	H1-receptor antagonist	Allergy		1985						1985	1997		3 European countries|2 African countries|3 Asian countries|3 South American countries|US|Canada	Cardiovascular|Immunologic|Liver|Skin		7BA5G9Y06Q	CC(C)(C)C1=CC=C(C=C1)C(O)CCCN2CCC(CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Terodiline				Antispasmodic	Calcium channel blockade, blocks cholinergic receptor	Urinary incontinence		1965						1989	1991		Worldwide	Cardiovascular		70KG06964W	CC(CC(C1=CC=CC=C1)C2=CC=CC=C2)NC(C)(C)C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Testosterone propionate			injectable	Hormones	Androgen-receptor modulation	Hypogonadism|Sexual dysfunction		1937						1952	1982		Bangladesh	Drug abuse		WI93Z9138A	CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tetrachlorosalicylanilide				Antimicrobial	Leakage of cell contents	Bacterial infection		1949						1961	1975		US|Japan	Skin		HNE676755I	OC1=C(Cl)C=C(Cl)C=C1C(=O)NC2=CC(Cl)=C(Cl)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tetracycline			pediatric	Antimicrobial	Protein synthesis inhibitor	Bacterial infection		1948						1959	1975		8 Asian countries|2 African countries|2 Australasian countries|US|Italy	Teeth; bone		F8VB5M810T	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tetrazepam				Sedative-hypnotic	Benzodiazepine site agonist	Hypnosedation		1960						1988	2013		EU	Dermatitis		FO92091VP8	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C3=CCCCC3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Thalidomide				Immunomodulator	? CNS mechanism	Hyperemesis		1957						1961	1961		Belgium|Finland|Indonesia|Canada|Brazil|Denmark|India|Singapore|Venezuela|UK|Germany	Nervous system|Teratogenicity		4Z8R6ORS6L	O=C1N(C2CCC(=O)NC2=O)C(=O)C3=C1C=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Thenalidine tartrate				Antihistamine	H1-receptor blocker	Allergy		1953						1958	1958		US|UK|Sweden|France|Cyprus|Australia|Finland|Norway|Canada	Hematologic: neutropenia		H581Q95SJA	O[C@H]([C@@H](O)C(O)=O)C(O)=O.CN1CCC(CC1)N(CC2=CC=CS2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Thiobutabarbital				Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation		1939						1981	1993		Germany	Urinary tract		2N0251U7JH	CCC(C)C1(CC)C(=O)NC(=S)NC1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Thioridazine				Antipsychotic	5HT2 receptor antagonist	Psychoses		1959						1961	2000		Worldwide	Retinopathy|Cardiovascular		N3D6TG58NI	CSC1=CC=C2SC3=CC=CC=C3N(CCC4CCCCN4C)C2=C1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Thorium dioxide				Radiography	Radiocontrast	Diagnostic imaging		1928						1931	1955		UK	Tumorigenicity		9XA7X17UQC	[O--].[O--].[Th+4]	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tick-borne encephalitis vaccine				Vaccines	Immunogenicity	Viral infection		1999						1999	2000		Germany	Hyperpyrexia				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tienilic acid		ticrynafen		Antihypertensive	Loop diuretic	Hypertension|Kidney stones		1976						1979	1980		Greece|Philippines|US|Brazil|Germany|Panama|France|India|Venezuela	Liver|Urinary tract		HC95205SY4	OC(=O)COC1=CC=C(C(=O)C2=CC=CS2)C(Cl)=C1Cl	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tilbroquinol				Antiprotozoal	Unknown	Diarrhea (amoebiasis)		1969						1996	1997		France|Morocco|Saudi Arabia|Switzerland	Liver|Nervous system		P6SB125NHA	CC1=CC(Br)=C(O)C2=NC=CC=C12	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Timonacic acid		thioproline		Antioxidant	Cysteine release and restoration of glutathione concentrations	Hepatitis		1975						1981	1982		France	Drug overdose (toxicity)		E5913T3IBL	OC(=O)C1CSCN1	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tocainide				Antiarrhythmic	Sodium channel blockade	Cardiac arrhythmia		1981						1986	1986		US	Hematologic: agranulocytosis|Aplastic anemia		27DXO59SAN	CC(N)C(=O)NC1=C(C)C=CC=C1C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tolcapone				Antiparkinsonian	COMT inhibitor	Parkinson's		1998						1998	1998		UK|Australia|Ireland|Spain|Portugal|Lithuania|Bulgaria|Canada	Liver		CIF6334OLY	CC1=CC=C(C=C1)C(=O)C2=CC(O)=C(O)C(=C2)[N+]([O-])=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tolrestat				Hypoglycemic	Aldase reductase inhibitor	Diabetes		1982						1995	1996		Worldwide	Liver		0T93LG5NMK	COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tranylcypromine				Antidepressant	MAOI	Depression		1961						1963	1964		Italy|Belgium|Venezuela|Canada	Cardiovascular|Drug interactions		3E3V44J4Z9	N[C@@H]1C[C@H]1C2=CC=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Trazodone				Antidepressant	Binds at 5-HT2 receptor	Depression		1973						1983	1985		Norway	Carcinogenic		YBK48BXK30	ClC1=CC(=CC=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Tretinoin				Retinoid	Modulates cell-cycle progression, cellular differentiation, cell survival and apoptosis	Acne		1973						1977	1988		Germany	Carcinogenic		5688UTC01R	CC(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(C)=C/C(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Triacetyldiphenolisatin				Laxative	âd mucosal tissue permeability	Constipation		1961						1967	1971		Australia|Germany|Italy|Canada|Cyprus|New Zealand|Venezuela	Photosensitivity; hepatotoxicity		ZHJ4JHL6HB	CC(=O)OC1=CC=C(C=C1)C2(C(=O)N(C(C)=O)C3=CC=CC=C23)C4=CC=C(OC(C)=O)C=C4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Triazolam				Sedative-hypnotic	GABA-A receptor binding	Hypnosedation		1978						1978	1979		Mauritius|Europe|Brazil|Oman	Nervous system|Psychiatric		1HM943223R	CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C4=CC(Cl)=CC=C4N12	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Trimethobenzamide			suppository	Antihistamine	?Chemoreceptor trigger zone	Motion sickness|GI infections|Medication- induced nausea		1959						1976	2007		US	Due to new FDA regulation; lack of effectiveness. Teratogenicity		W2X096QY97	COC1=CC(=CC(OC)=C1OC)C(=O)NCC2=CC=C(OCCN(C)C)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Triparanol				Antilipemic	Î´ 24-reductase inhibitor	Hyperlipidemia		1959						1961	1962		US|France	Sensory systems|Skin		63S8C3RXGS	CCN(CC)CCOC1=CC=C(C=C1)C(O)(CC2=CC=C(Cl)C=C2)C3=CC=C(C)C=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Troglitazone				Hypoglycemic	PPARs activation	Diabetes		1997						1997	1997		UK|Switzerland|Peru|Jamaica|Chile|US|Canada	Liver		I66ZZ0ZN0E		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Trovafloxacin				Antimicrobial	Inhibits DNA gyrase	Bacterial infection		1997						1997	1999		European Union|Philippines|Syria|Vietnam|Singapore|Canada|US	Liver		9F388J00UK	N[C@H]1[C@@H]2CN(C[C@H]12)C3=NC4=C(C=C3F)C(=O)C(=CN4C5=CC=C(F)C=C5F)C(O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Urethane				Solvent	?Interferes with pyrimidine metabolism	Cancer (CML)		1933						1943	1963		Brazil|Cuba|Denmark|Egypt|Japan|Thailand|US|Canada|Italy|Greece|Denmark|Venezuela|France	Hematologic|Liver|Tumorigenicity		3IN71E75Z5	CCOC(N)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Valdecoxib				Analgesic	COX-2 inhibitor	Analgesia		2001						2003	2005		US|Canada|Europe|India	Cardiovascular; skin		2919279Q3W	CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(N)(=O)=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Veralipride				Neuroleptic	Selective antagonism of hypothalamic D2 receptors	Climacteric		1979						1982	2007		Europe|Brazil (reference to EMA)	Psychiatric		S7064109UD	COC1=C(OC)C(=CC(=C1)S(N)(=O)=O)C(=O)NCC2CCCN2CC=C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Vigabatrin		gamma-vinyl- GABA		Antiepileptic	Inhibits GABA transaminase (GABA-T)	Hypnosedation		1989						1989	1991		Norway	Not medically justified; neurotoxicity		GR120KRT6K	NC(CCC(O)=O)C=C	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Vinbarbital				Sedative-hypnotic	GABA-A receptor modulation	Hypnosedation		1939						1975	1984		Sweden	Drug abuse		7NZH2C1T6O	CC\C=C(/C)C1(CC)C(=O)NC(=O)NC1=O	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Vincamine				Nootropic	Unclear	Meniere's disease|Vertigo		1955						1974	1980		Hungary|Germany	Cardiovascular|Hematologic		996XVD0JHT	CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Vitamin B complex			injectable	Hematinic	Co-factor for biochemical transformation	Anemia		1949						1953	2008		Iraq	Immunologic				https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Vitamin E			injectable	Antioxidant	Downregulation of ICAM-1 and VCAM-1	Retinal deterioration in neonates		1983						1984	1984		US	Death|Hematologic|Liver|Urinary tract		H4N855PNZ1		https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Xenazoic acid		xenalamine		Antimicrobial	? Inhibits intracellular stages viral biological cycle	Viral infection		1960						1965	1965		Belgium|France|Venezuela	Liver		KDU8VH09O8	CCOC(NC1=CC=C(C=C1)C(O)=O)C(=O)C2=CC=C(C=C2)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Ximelagatran				Anticoagulant	Direct thrombin inhibitor	DVT|Stroke		2005						2006	2006		Europe|Brazil	Liver		49HFB70472	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)C(=N)NO	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Zimeldine				Antidepressant	5 HT reuptake inhibitor	Depression		1982						1982	1983		Worldwide	Liver|Nervous system		3J928617DW	CN(C)C\C=C(\C1=CC=C(Br)C=C1)C2=CN=CC=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Zipeprol dihydrochloride				Antitussive	Laryngeal nerve stimulation; excitation of tracheo-bronchial receptors	Cough		1971						1984	1991		Philippines|Brazil|Spain|Switzerland|Turkey	Drug abuse|Drug dependence|Nervous system		U6WT9D8ASL	Cl.Cl.COC(CN1CCN(CC(O)C(OC)C2=CC=CC=C2)CC1)C3=CC=CC=C3	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Zomepirac				Analgesic	COX-1 & COX-2 inhibition	Analgesia		1979						1981	1983		Worldwide	Immunologic|Urinary tract		822G987U9J	CN1C(CC(O)=O)=CC(C)=C1C(=O)C2=CC=C(Cl)C=C2	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Zopiclone				Sedative-hypnotic	GABA-A receptor binding	Hypnosedation		1985						1985	1986		Israel|Norway	Carcinogenicity		03A5ORL08Q	CN1CCN(CC1)C(=O)OC2N(C(=O)C3=C2N=CC=N3)C4=CC=C(Cl)C=N4	https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0553-2
Withdrawn	Adenosine phosphate							All drug products containing adenosine phosphate.										US			415SHH325A	NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Adrenal cortex							All drug products containing adrenal cortex.										US					https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Alatrofloxacin mesylate							All drug products containing alatrofloxacin mesylate.										US			2IXX802851	CS(O)(=O)=O.C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]1[C@H]2CN(C[C@@H]12)C3=NC4=C(C=C3F)C(=O)C(=CN4C5=CC=C(F)C=C5F)C(O)=O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Aminopyrine							All drug products containing aminopyrine.										US			01704YP3MO	CN(C)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Astemizole							All drug products containing astemizole.										US			7HU6337315	COC1=CC=C(CCN2CCC(CC2)NC3=NC4=C(C=CC=C4)N3CC5=CC=C(F)C=C5)C=C1	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Azaribine							All drug products containing azaribine.										US			K1U80DO9EB	CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N2N=CC(=O)NC2=O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Benoxaprofen							All drug products containing benoxaprofen.										US			17SZX404IM	CC(C(O)=O)C1=CC=C2OC(=NC2=C1)C3=CC=C(Cl)C=C3	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Bithionol							All drug products containing bithionol.										US			AMT77LS62O	OC1=C(Cl)C=C(Cl)C=C1SC2=CC(Cl)=CC(Cl)=C2O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Bromfenac sodium							All drug products containing bromfenac sodium (except ophthalmic solutions).										US			8ECV571Y37	O.O.O.[Na+].[Na+].NC1=C(CC([O-])=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2.NC3=C(CC([O-])=O)C=CC=C3C(=O)C4=CC=C(Br)C=C4	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Butamben							All parenteral drug products containing butamben.										US			EFW857872Q	CCCCOC(=O)C1=CC=C(N)C=C1	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Camphorated oil							All drug products containing camphorated oil.										US			75IZZ8Y727		https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Carbetapentane citrate							All oral gel drug products containing carbetapentane citrate.										US			4SH0MFJ5HJ	OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Casein, iodinated							All drug products containing iodinated casein.										US					https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Cerivastatin sodium							All drug products containing cerivastatin sodium.										US			6Q18G1060S	[Na+].COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C(N=C1C(C)C)C(C)C	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Chloramphenicol							All oral drug products containing chloramphenicol.										US			66974FR9Q1	OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Chlorhexidine gluconate							All tinctures of chlorhexidine gluconate formulated for use as a patient preoperative skin preparation.										US			MOR84MUD8E	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Chlormadinone acetate							All drug products containing chlormadinone acetate.										US			0SY050L61N	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Chloroform							All drug products containing chloroform.										US			7V31YC746X	ClC(Cl)Cl	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Cisapride							All drug products containing cisapride.										US			UVL329170W	CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(Cl)=C(N)C=C3OC	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Cobalt							All drug products containing cobalt salts (except radioactive forms of cobalt and its salts and cobalamin and its derivatives).										US			3G0H8C9362	[Co]	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Dexfenfluramine hydrochloride							All drug products containing dexfenfluramine hydrochloride.										US			PM28L0FHNP	Cl.CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Diamthazole dihydrochloride							All drug products containing diamthazole dihydrochloride.										US			3LF09TBB5W	Cl.Cl.CCN(CC)CCOC1=CC2=C(C=C1)N=C(S2)N(C)C	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Dibromsalan							All drug products containing dibromsalan.										US			N9900K2RBT	OC1=CC=C(Br)C=C1C(=O)NC2=CC=C(Br)C=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Diethylstilbestrol							All oral and parenteral drug products containing 25 milligrams or more of diethylstilbestrol per unit dose.										US			731DCA35BT	CC\C(C1=CC=C(O)C=C1)=C(\CC)C2=CC=C(O)C=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Dihydrostreptomycin sulfate							All drug products containing dihydrostreptomycin sulfate.										US			T7D4876IUE	OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]3NC(N)=N)O[C@@H](C)[C@]2(O)CO.CN[C@H]4[C@H](O)[C@@H](O)[C@H](CO)O[C@H]4O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]6NC(N)=N)O[C@@H](C)[C@]5(O)CO	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Dipyrone							All drug products containing dipyrone.										US			6429L0L52Y	O.[Na+].CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Encainide hydrochloride							All drug products containing encainide hydrochloride.										US			4CH7J36N9S	Cl.COC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2CCC3CCCCN3C	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Esmolol hydrochloride							All parenteral dosage form drug products containing esmolol hydrochloride that supply 250 milligrams/milliliter of concentrated esmolol per 10-milliliter ampule.										US			V05260LC8D	Cl.COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Etretinate							All drug products containing etretinate.										US			65M2UDR9AG	CCOC(=O)\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)C=C(OC)C(C)=C1C	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Fenfluramine hydrochloride							All drug products containing fenfluramine hydrochloride.										US			3KC089243P	Cl.CCNC(C)CC1=CC(=CC=C1)C(F)(F)F	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Flosequinan							All drug products containing flosequinan.										US			6NB119DLU7	CN1C=C([S+](C)[O-])C(=O)C2=C1C=C(F)C=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Gatifloxacin							All drug products containing gatifloxacin (except ophthalmic solutions).										US			L4618BD7KJ	O.O.O.COC1=C(N2CCNC(C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)C4CC4.COC5=C(N6CCNC(C)C6)C(F)=CC7=C5N(C=C(C(O)=O)C7=O)C8CC8	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Gelatin							All intravenous drug products containing gelatin.										US			2G86QN327L		https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Glycerol, iodinated							All drug products containing iodinated glycerol.										US			8C0LU36AR9		https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Gonadotropin, chorionic							All drug products containing chorionic gonadotropins of animal origin.										US			20ED16GHEB		https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Grepafloxacin							All drug products containing grepafloxacin.										US			L1M1U2HC31	CC1CN(CCN1)C2=CC3=C(C(=O)C(=CN3C4CC4)C(O)=O)C(C)=C2F	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Mepazine							All drug products containing mepazine hydrochloride or mepazine acetate.										US			PH34873A38	CN1CCCC(CN2C3=CC=CC=C3SC4=CC=CC=C24)C1	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Metabromsalan							All drug products containing metabromsalan.										US			8Q21Y09R21	OC1=C(Br)C=C(Br)C=C1C(=O)NC2=CC=CC=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Methapyrilene							All drug products containing methapyrilene.										US			A01LX40298	CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Methopholine							All drug products containing methopholine.										US			72L4ZT2W1P	COC1=C(OC)C=C2C(CCC3=CC=C(Cl)C=C3)N(C)CCC2=C1	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Methoxyflurane							All drug products containing methoxyflurane.										US			30905R8O7B	COC(F)(F)C(Cl)Cl	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Mibefradil dihydrochloride							All drug products containing mibefradil dihydrochloride.										US			842TUP3PQ8	Cl.Cl.COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Nitrofurazone							All drug products containing nitrofurazone (except topical drug products formulated for dermatologic application).										US			X8XI70B5Z6	NC(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Nomifensine maleate							All drug products containing nomifensine maleate.										US			76S8CUH5MR	OC(=O)\C=C/C(O)=O.CN1CC(C2=CC=CC=C2)C3=C(C1)C(N)=CC=C3	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Novobiocin sodium							All drug products containing novobiocin sodium.										US			Q9S9NQ5YIY	[Na+].CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C([O-])=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)O3)OC1(C)C	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Oxyphenisatin							All drug products containing oxyphenisatin.										US			3BT0VQG2GQ	OC1=CC=C(C=C1)C2(C(=O)NC3=C2C=CC=C3)C4=CC=C(O)C=C4	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Oxyphenisatin acetate							All drug products containing oxyphenisatin acetate.										US			U0Y1YAL65X	CC(=O)OC1=CC=C(C=C1)C2(C(=O)NC3=C2C=CC=C3)C4=CC=C(OC(C)=O)C=C4	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Pemoline							All drug products containing pemoline.										US			7GAQ2332NK	NC1=NC(=O)C(O1)C2=CC=CC=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Pergolide mesylate							All drug products containing pergolide mesylate.										US			55B9HQY616	CS(O)(=O)=O.CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=C3C2=CC=C4	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Phenacetin							All drug products containing phenacetin.										US			ER0CTH01H9	CCOC1=CC=C(NC(C)=O)C=C1	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Phenformin hydrochloride							All drug products containing phenformin hydrochloride.										US			91XC93EU03	Cl.NC(=N)NC(=N)NCCC1=CC=CC=C1	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Phenylpropanolamine							All drug products containing phenylpropanolamine.										US			33RU150WUN		https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Pipamazine							All drug products containing pipamazine.										US			653552FH1N	NC(=O)C1CCN(CCCN2C3=CC=CC=C3SC4=CC=C(Cl)C=C24)CC1	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride, and bisacodyl							All drug products containing polyethylene glycol 3350, sodium chloride, sodium bicarbonate, and potassium chloride for oral solution, and 10 milligrams or more of bisacodyl delayed-release tablets.										US					https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Potassium arsenite							All drug products containing potassium arsenite.										US			HQE48MPP30	[K+].[O-][As]=O.O[As](O)O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Potassium chloride							All solid oral dosage form drug products containing potassium chloride that supply 100 milligrams or more of potassium per dosage unit (except for controlled-release dosage forms and those products formulated for preparation of solution prior to ingestion).										US			660YQ98I10	[Cl-].[K+]	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Povidone							All intravenous drug products containing povidone.										US			FZ989GH94E		https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Propoxyphene							All drug products containing propoxyphene.										US			S2F83W92TK	CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C2=CC=CC=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Rapacuronium bromide							All drug products containing rapacuronium bromide.										US			65Q4QDG4KC	[Br-].CCC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCCCC5)[N+]6(CC=C)CCCCC6	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Reserpine							All oral dosage form drug products containing more than 1 milligram of reserpine.										US			8B1QWR724A	CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Rofecoxib							All drug products containing rofecoxib.										US			0QTW8Z7MCR	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Sibutramine hydrochloride							All drug products containing sibutramine hydrochloride.										US			OGM0YHD1WF	O.Cl.CC(C)CC(N(C)C)C1(CCC1)C2=CC=C(Cl)C=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Sparteine sulfate							All drug products containing sparteine sulfate.										US			GQ3J2TLZ7E	O.O.O.O.O.OS(O)(=O)=O.C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Sulfadimethoxine							All drug products containing sulfadimethoxine.										US			30CPC5LDEX	COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Sulfathiazole							All drug products containing sulfathiazole (except for those formulated for vaginal use).										US			Y7FKS2XWQH	NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CS2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Suprofen							All drug products containing suprofen (except ophthalmic solutions).										US			988GU2F9PE	OC[C@@H](O)[C@@H](O)CC(=O)C=O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Ethyl nitrite							All drug products containing sweet spirits of nitre.										US			8C7CJ279RV	CCON=O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Tegaserod maleate							All drug products containing tegaserod maleate.										US			E5XNT3RF5A	OC(=O)\C=C/C(O)=O.CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Temafloxacin hydrochloride							All drug products containing temafloxacin hydrochloride.										US			OC5IGJ7J6I	Cl.CC1CN(CCN1)C2=CC3=C(C=C2F)C(=O)C(=CN3C4=CC=C(F)C=C4F)C(O)=O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Terfenadine							All drug products containing terfenadine.										US			7BA5G9Y06Q	CC(C)(C)C1=CC=C(C=C1)C(O)CCCN2CCC(CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	3,3-,4-,5-tetrachlorosalicylanilide							All drug products containing 3,3-,4-,5-tetrachlorosalicylanilide.										US			HNE676755I	OC1=C(Cl)C=C(Cl)C=C1C(=O)NC2=CC(Cl)=C(Cl)C=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Tetracycline							All liquid oral drug products formulated for pediatric use containing tetracycline in a concentration greater than 25 milligrams/milliliter.										US			F8VB5M810T	CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Ticrynafen							All drug products containing ticrynafen.										US			HC95205SY4	OC(=O)COC1=CC=C(C(=O)C2=CC=CS2)C(Cl)=C1Cl	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Tribromsalan							All drug products containing tribromsalan.										US			6MCE3VTF0O	OC1=C(Br)C=C(Br)C=C1C(=O)NC2=CC=C(Br)C=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Trichloroethane							All aerosol drug products intended for inhalation containing trichloroethane.										US			113C650IR1	CC(Cl)(Cl)Cl	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Troglitazone							All drug products containing troglitazone.										US			I66ZZ0ZN0E		https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Trovafloxacin mesylate							All drug products containing trovafloxacin mesylate.										US			0P1LKO80WN	CS(O)(=O)=O.N[C@H]1[C@@H]2CN(C[C@H]12)C3=NC4=C(C=C3F)C(=O)C(=CN4C5=CC=C(F)C=C5F)C(O)=O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Urethane							All drug products containing urethane.										US			3IN71E75Z5	CCOC(N)=O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Valdecoxib							All drug products containing valdecoxib.										US			2919279Q3W	CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(N)(=O)=O	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Vinyl chloride							All aerosol drug products containing vinyl chloride.										US			WD06X94M2D	ClC=C	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Zirconium							All aerosol drug products containing zirconium.										US			C6V6S92N3C	[Zr]	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
Withdrawn	Zomepirac sodium							All drug products containing zomepirac sodium.										US			Y0185WZ209	O.O.[Na+].CN1C(CC([O-])=O)=CC(C)=C1C(=O)C2=CC=C(Cl)C=C2	https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24
shortage	ADEKs Chewable Tablets											2011-07-26	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=811									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Alefacept Injection											2012-01-11	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=885									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Aminohippurate Sodium											2015-07-14	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1135							SUO3KVS1O9	[Na+].NC1=CC=C(C=C1)C(=O)NCC([O-])=O	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Ammonium Chloride Injection											2017-01-31	2017	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=933									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Amphotericin B Cholesteryl Sulfate Complex Injection											2014-10-20	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=894									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Aripiprazole Short-Acting Intramuscular Injection											2015-07-30	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1203									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Asparaginase Injection											2013-02-07	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=958									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Bismuth Subsalicylate/Metronidazole/Tetracycline (Helidac Therapy)											2014-04-25	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1098									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Boceprevir Capsules											2015-12-09	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1154									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Buprenorphine and Naloxone Tablets											2013-01-23	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=967									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Carisoprodol and Aspirin											2017-05-22	2017	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1275									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Castor Oil, Balsam Peru, and Trypsin Topical Products											2016-02-01	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1179									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Chloral Hydrate Oral Solution and Capsules											2012-11-05	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=902									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Cyclophosphamide Tablets											2014-08-11	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1116									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Denileukin Diftitox Injection											2015-03-25	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1009									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Droperidol Injection											2015-06-11	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=818									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Drotrecogin Alfa (Activated) Injection											2011-10-26	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=855									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Edrophonium Chloride and Atropine Injection											2015-08-20	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1204									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Emergency Drug Syringes											2010-08-05	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=602									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Epinephrine Metered Dose Inhaler											2012-05-24	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=848									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Ergonovine Injection											2011-02-09	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=732									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Erythromycin Ethylsuccinate and Sulfisoxazole Oral Suspension											2014-07-17	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1113									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Ethinyl Estradiol 50 mcg and Norethindrone 1 mg Tablets											2012-11-12	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=904									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Ezetimibe and Atorvastatin Tablets											2015-09-16	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1084									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Flunisolide Oral Inhaler											2010-12-15	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=688									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Formoterol Fumarate											2016-05-26	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=720							W34SHF8J2K	O.O.OC(=O)\C=C\C(O)=O.COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC(NC=O)=C(O)C=C2)C=C1.COC3=CC=C(C[C@@H](C)NC[C@H](O)C4=CC(NC=O)=C(O)C=C4)C=C3	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Ganciclovir Capsules											2013-05-24	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=539									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Gatifloxacin 0.3% Ophthalmic Solution											2011-03-09	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=745									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Gemtuzumab Ozogamicin Injection											2010-10-19	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=692									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Gold Sodium Thiomalate Injection											2011-12-12	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=725									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Heparin Sodium (Beef) injection											2010-11-18	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=702									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Hexachlorophene 3% Detergent Cleanser (Phisohex)											2013-10-02	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1059									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Inamrinone Injection											2011-05-04	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=430									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Ipecac Syrup											2010-10-12	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=468							62I3C8233L		https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Iron Polysaccharide Oral Liquid											2011-01-26	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=617									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Japanese Encephalitis Virus Inactivated Vaccine											2013-05-22	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=735									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Kanamycin Sulfate Injection											2013-01-31	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=522									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Lepirudin Injection											2012-05-23	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=924									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Levothyroxine (Levothroid) Oral Tablets											2013-07-11	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1041									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Mannitol Inhalation Capsules											2014-09-12	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1096									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Mebendazole Tablets											2011-10-27	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=750									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Mephobarbital Tablets											2011-02-03	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=730									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Mesalamine 400 mg Delayed-Release Tablet (Asacol)											2013-04-05	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1017									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Multivitamin Oral Liquid											2016-11-15	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1257									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Neomycin Oral Solution											2012-02-28	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=825									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Neostigmine Bromide Tablets											2014-05-14	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1060									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Norfloxacin Tablets (Noroxin)											2014-04-29	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1099									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Nystatin Vaginal Tablets											2012-11-13	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=865									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Oral Sodium Phosphate (Over-the-Counter) Solution											2013-06-12	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=549									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Otic Unapproved Prescription Preparations Containing Benzocaine or Chloroxylenol											2015-07-28	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1202									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Oxycodone/Acetaminophen Oral Solution											2015-05-13	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1117									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Permethrin 1% Lotion											2015-09-23	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1211									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Pilocarpine Ophthalmic Gel											2013-08-06	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1048									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Piperacillin Sodium for Injection											2011-04-22	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=756									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Prenatal Multivitamins with Minerals											2014-04-23	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1095									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Reserpine Oral Tablets											2016-04-15	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=975									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Scopolamine Injection											2015-02-19	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=39									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Scopolamine Hydrobromide Ophthalmic Solution											2013-03-05	2013	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=953									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Synthetic Conjugated Estrogen											2016-08-05	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1087									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Tetanus Toxoid Adsorbed											2014-09-04	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1125							K3W1N8YP13		https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Tetracaine Topical Solution											2010-08-03	2010	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=567									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Thiopental Injection											2011-01-21	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=563									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Ticarcillin Clavulanate											2014-11-17	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=802									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Ticlopidine Tablets											2015-04-01	2015	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=661									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Tinzaparin Sodium Injection											2011-07-01	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=749									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	TriHIBit â Diphtheria, Tetanus Toxoid, and Acellular Pertussis with Haemophilus b Conjugate Vaccine (DTaP with Haemophilus b Conjugate)											2011-04-08	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=763									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Tripedia â Diphtheria, Tetanus Toxoid, and Acellular Pertussis Vaccine (DTaP)											2011-04-08	2011	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=764									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Tromethamine Injection											2016-05-20	2016	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=687									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Verapamil Extended Release Tablets											2012-06-20	2012	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=928									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Vitamin E Aqueous Oral Solution											2017-01-25	2017	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=965									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
shortage	Warfarin for Injection											2014-07-01	2014	https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=1110									https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List?page=DrugsNoLongerAvailable
Marketed (restrictions)	Alosetron	Lotronex			5HT3receptor antag				2000							2000		US	Severe colitis	2002	13Z9HTH115	CN1C2=CC=CC=C2C3=C1CCN(CC4=C(C)N=CN4)C3=O	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Diethylpropion hydrochloride	Tenuate dospan			Antiobesity				1971							2000		EU	Primary pulmonary hypertension		19V2PL39NG	Cl.CCN(CC)C(C)C(=O)C1=CC=CC=C1	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Amineptine	Survector														2000		SP	Hepatotoxicity		27T1I13L6G	OC(=O)CCCCCCNC1C2=CC=CC=C2CCC3=CC=CC=C13	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Aprotinin	Trasylol			Perioperative blood loss				1993							2007|2008		US	Increased risks of complications or death		04XPW8C0FL		https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Astemizole	Hismanal			Antihistamine				1988							1999		US	Fatal arrhythmia		7HU6337315	COC1=CC=C(CCN2CCC(CC2)NC3=NC4=C(C=CC=C4)N3CC5=CC=C(F)C=C5)C=C1	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Benzbromarone	Desuri			Hyperuricmic				1976							2003		FR	Cytolytic liver damage		4POG0RL69O	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C3=C(O1)C=CC=C3	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Bromfenac	Duract			NSAID				1997							1998		US	Liver toxicity		864P0921DW	NC1=C(CC(O)=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Cerivastatin	Baycol			Statin				1997							2001		US	Muscle damage leading to kidney failure		AM91H2KS67	COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Chloral hydrate	Notec|Somnos			Hynotic				1869							2001		FR|US	Mutagenic/carcinogenic in animals		418M5916WG	OC(O)C(Cl)(Cl)Cl	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Cisapride	Propulsid			Gastrointestinal/heartburn				1993							2000		US	Fatal arrhythmia		UVL329170W	CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(Cl)=C(N)C=C3OC	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Cloforex				Anorexiant sympathominietic											2000		EU	CV toxicity		2QJT5ZC1L6	CCOC(=O)NC(C)(C)CC1=CC=C(Cl)C=C1	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Droperidol				Schizophrenia				1970							2001		US|UK	QTc prolongation		O9U0F09D5X	FC1=CC=C(C=C1)C(=O)CCCN2CCC(=CC2)N3C(=O)NC4=C3C=CC=C4	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Ebrotidine	Ebrocit			H2 antagonist				1997							1998		Sp	Hepatotoxicity		TMZ3IBW2OW	NC(=N)NC1=NC(CSCCN\C=N\S(=O)(=O)C2=CC=C(Br)C=C2)=CS1	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Etretinate	Tegison			Antipsoriatic				1986							1999		US	Birth defects		65M2UDR9AG	CCOC(=O)\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)C=C(OC)C(C)=C1C	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Eudipine	Parkinson	Bupidine		Muscarinic and NMDA receptor antagonist				1979							2000		Ger	Severe CV risks and arrhythmias		864V2Q084H	OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C2=C(COCCN)NC(C)=C(C2C3=CC=CC=C3Cl)C(=O)OC	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Febarbamate	Atrium|Tymium			w/phenobarbital				1967							1997-2001		FR	Cytoytic hepatitis		5Z48ONN38P	CCCCOCC(CN1C(=O)NC(=O)C(CC)(C1=O)C2=CC=CC=C2)OC(N)=O	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Grepafloxacin	Raxar			Anti-infective/quinolone				1997							1999		US	Fatal arrhythmia		L1M1U2HC31	CC1CN(CCN1)C2=CC3=C(C(=O)C(=CN3C4CC4)C(O)=O)C(C)=C2F	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Levomethadyl	ORLAAM			Opiate dependence				1993							2003		US|EU	Fatal arrhythmia		QZH7WR4VKJ	CC[C@H](O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Lumiracoxib	Prexige			NSAID (cox-2)				2005							2007		EU	Benefits donât outweigh risks		V91T9204HU	CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(O)=O)=C1	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Medifoxamine	Cledial			Antidepressant											1999		FR	Hepatocellular damage		KWU7C2A1NT	CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	MIbefradil	Posicar			Antihypertensive				1997							1998		US	Fatal arrhythmia		27B90X776A	COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Mixed amphetamine salts	Adderall XR														2005		Canada	Stroke risk				https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Nefazodone	Dutonin|Serzone|Nefardar|Reseril|Rulivan|Serzonil			Phenypiperazine derivative antidepressant				1995-1999							2003		EU|US	Liver failure		59H4FCV1TF	CCC1=NN(CCCN2CCN(CC2)C3=CC=CC(Cl)=C3)C(=O)N1CCOC4=CC=CC=C4	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Nimesulide	Nimed|Antofloxil|Guaxan|Aulin			NSAID				1986|1995							2002		EU	Hepatotoxicity		V4TKW1454M	CS(=O)(=O)NC1=CC=C(C=C1OC2=CC=CC=C2)[N+]([O-])=O	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Pemoline	Cylert			ADHD				1998							1999|2005		UK|US	Cytolytic hepatotoxicity/liver disease		7GAQ2332NK	NC1=NC(=O)C(O1)C2=CC=CC=C2	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Phentermine	Duromine			Antiobesity											2000		EU|US	Valve disease		C045TQL4WP	CC(C)(N)CC1=CC=CC=C1	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Phenylpropanolamine	Dexatrim|propagest			Antiobesity											2000			Stroke risk		33RU150WUN		https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Rapacuronium	Raplon			Anesthetic				1999							2001		US	Severe breathing difficulties		GG1LBM463S	CCC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCCCC5)[N+]6(CC=C)CCCCC6	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Rimonabant	Acomplia			Cannabinoid				2006							2008		EU	Depression and suicide risk		RML78EN3XE	CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=CC=C(Cl)C=C3Cl)C4=CC=C(Cl)C=C4	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Rofecoxib	Vioxx			NSAID (cox-2)				1999							2004		US	Heart attack/stroke		0QTW8Z7MCR	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Sertindole	Serdolect			Antipsychotic				1996							1998		UK|SP	Torsades de pointe QTC prolongation sudden death		GVV4Z879SP	FC1=CC=C(C=C1)N2C=C(C3CCN(CCN4CCNC4=O)CC3)C5=C2C=CC(Cl)=C5	https://academic.oup.com/toxsci/article/110/1/40/1666320
Marketed (restrictions)	Sibutramine	Reductil|Meridia|Reduxate|Ectiva			Antiobesity											2002		IT	Arrythmia and hypertension	2002	WV5EC51866	CC(C)CC(N(C)C)C1(CCC1)C2=CC=C(Cl)C=C2	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Tegaserod	Zelnorm														2007			Heart attack/stroke		458VC51857	CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Terfenadine	Seldane			Antihistamine				1985							1998		US|OM|FR|GER	Fatal arrhythmia		7BA5G9Y06Q	CC(C)(C)C1=CC=C(C=C1)C(O)CCCN2CCC(CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Tolcapone	Tasmar			Anti-parkinonian COMT inhibitor				1998							1998		EU	Hepatocellular toxicity		CIF6334OLY	CC1=CC=C(C=C1)C(=O)C2=CC(O)=C(O)C(=C2)[N+]([O-])=O	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Trovafloxacin	Trovan	alatrovafloxacin		Anti-infective				1997|1998							1999|2001		US|EU	Liver toxicity		9F388J00UK	N[C@H]1[C@@H]2CN(C[C@H]12)C3=NC4=C(C=C3F)C(=O)C(=CN4C5=CC=C(F)C=C5F)C(O)=O	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Troglitazone	Rezulin			Antidiabetic				1997							2000		US	Liver toxicity		I66ZZ0ZN0E		https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Valdecoxib	Bextra			NSAID (cox-2)				2001							2005		US	Skin disease		2919279Q3W	CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(N)(=O)=O	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Ximelagatran	Exanta	melagatran		Stroke/thromboembolic				2005							2006		EU	Hepatotoxicity		49HFB70472	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)C(=N)NO	https://academic.oup.com/toxsci/article/110/1/40/1666320
Withdrawn	Terfenadine	Seldane														1998	1998-02-01				7BA5G9Y06Q	CC(C)(C)C1=CC=C(C=C1)C(O)CCCN2CCC(CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4	https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm115979.htm
Withdrawn	Mibefradil	Posicor														1998	1998-06-01				27B90X776A	COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C	https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm115979.htm
Withdrawn	Astemizole	Hismanal														1999	1999-07-01				7HU6337315	COC1=CC=C(CCN2CCC(CC2)NC3=NC4=C(C=CC=C4)N3CC5=CC=C(F)C=C5)C=C1	https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm115979.htm
Withdrawn	Cisapride	Propulsid														2000	2000-01-01				UVL329170W	CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(Cl)=C(N)C=C3OC	https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm115979.htm
Withdrawn	efalizumab	RAPTIVA							2003	2003-10-28	US					2009	2009-04-08	US			XX2MN88N5D		http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	trasylol	APROTININ							1993	1993-12-29	US					2007	2007-11-05	US			04XPW8C0FL		http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	tegaserod	ZELNORM							2002	2002-07-24	US					2007	2007-03-30	US			458VC51857	CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	gatifloxacin	TEQUIN							1999	1999-12-17	US					2006	2006-05-01	US			L4618BD7KJ	O.O.O.COC1=C(N2CCNC(C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)C4CC4.COC5=C(N6CCNC(C)C6)C(F)=CC7=C5N(C=C(C(O)=O)C7=O)C8CC8	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	technetium (99m TC) fanolesomab	NEUTROSPEC							2004	2004-07-02	US					2005	2005-12-19	US			AMF7KOE318		http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	hydromorphone	PALLADONE							2004	2004-09-24	US					2005	2005-07-13	US			Q812464R06	CN1CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@@H]2CCC4=O)=C35	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	valdecoxib	BEXTRA							2001	2001-11-16	US					2005	2005-04-07	US			2919279Q3W	CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(N)(=O)=O	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	natalizumab	TYSABRI							2004	2004-11-23	US					2005	2005-02-28	US			3JB47N2Q2P		http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	rofecoxib	VIOXX							1999	1999-05-20	US					2004	2004-09-29	US			0QTW8Z7MCR	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	levomethadyl	ORLAAM							1993	1993-07-09	US					2003	2003-09-02	US			QZH7WR4VKJ	CC[C@H](O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	cerivastatin	BAYCOL							1997	1997-06-26	US					2001	2001-08-08	US			AM91H2KS67	COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	rapacuronium	RAPLON							1999	1999-08-18	US					2001	2001-03-30	US			GG1LBM463S	CCC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCCCC5)[N+]6(CC=C)CCCCC6	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	alosetron	LOTRONEX							2000	2000-02-09	US					2000	2000-11-28	US			13Z9HTH115	CN1C2=CC=CC=C2C3=C1CCN(CC4=C(C)N=CN4)C3=O	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	cisapride	PROPULSID							1993	1993-07-29	US					2000	2000-03-24	US			UVL329170W	CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(Cl)=C(N)C=C3OC	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	troglitazone	REZULIN							1997	1997-01-29	US					2000	2000-03-21	US			I66ZZ0ZN0E		http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	grepafloxacin	RAXAR							1997	1997-11-06	US					1999	1999-08-11	US			L1M1U2HC31	CC1CN(CCN1)C2=CC3=C(C(=O)C(=CN3C4CC4)C(O)=O)C(C)=C2F	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	bromfenac	DURACT							1997	1997-07-15	US					1998	1998-06-22	US			864P0921DW	NC1=C(CC(O)=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	mibefradil	POSICOR							1997	1997-06-20	US					1998	1998-06-08	US			27B90X776A	COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C	http://www.worstpills.org/includes/page.cfm?op_id=552
Withdrawn	dexfenfluramine	REDUX							1996	1996-06-01	US					1997	1997-09-15	US			E35R3G56OV	CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F	http://www.worstpills.org/includes/page.cfm?op_id=552
